Category: Americas

  • MIL-OSI Canada: Statement from Premier Pillai on the Ontario election

    Statement from Premier Pillai on the Ontario election
    zaburke

    Premier Ranj Pillai has issued the following statement:

    “On behalf of the Government of Yukon, I would like to congratulate Premier Doug Ford on his government’s re-election in yesterday’s provincial election in Ontario.

    “Premier Ford has been given a renewed mandate to serve the people of Ontario. I look forward to continuing our collaboration and strengthening the relationship between our jurisdictions and our country. Strong partnerships between provinces and territories are essential to tackling the challenges and opportunities ahead.

    “I wish Premier Ford and his team success as they work on behalf of Ontarians and I look forward to continuing our work together around the Premiers’ table, in the spirit of cooperation and shared prosperity.”
     

    MIL OSI Canada News

  • MIL-OSI USA: Computational Astrophysicist Daniel Anglés-Alcázar Awarded Sloan Research Fellowship

    Source: US State of Connecticut

    Daniel Anglés-Alcázar, assistant professor of physics, has been awarded a 2025 Sloan Research Fellowship, one of the most competitive honors for early-career researchers in the United States and Canada.  

    Anglés-Alcázar was one of 126 scientists selected by the Alfred P. Sloan Foundation for the fellowship, which recognizes researchers for their exceptional creativity and potential to lead in their fields. The fellowship provides a two-year, $75,000 grant to support research at the recipient’s discretion. 

    Daniel Anglés-Alcázar, assistant professor of physics and 2025 Sloan Research Fellow. (Photo courtesy of Daniel Anglés-Alcázar).

    “It’s a great honor to be selected as a Sloan Fellow,” says Anglés-Alcázar. “This is a significant recognition for our research program, and I am very grateful to the long-term collaborators and mentors that have supported me throughout my career.” 

    “The Sloan Research Fellows represent the very best of early-career science, embodying the creativity, ambition, and rigor that drive discovery forward,” says Adam F. Falk, president of the Alfred P. Sloan Foundation. “These extraordinary scholars are already making significant contributions, and we are confident they will shape the future of their fields in remarkable ways.” 

    A computational astrophysicist, Anglés-Alcázar’s research focuses on developing simulations on supercomputers to understand how galaxies form and evolve. He uses theoretical models to interpret observations of galaxies, including how supermassive black holes impact galaxy evolution.  

    Observations suggest that when supermassive black holes grow, they release a huge amount of energy in the form of powerful winds or large-scale jets. However, the details of this process remain a mystery, according to Anglés-Alcázar.  

    “It’s still a big enigma,” he says. “In our models, we can make predictions of what happens when supermassive black holes at the center of galaxies power these large-scale winds or jets. Based on those models, we can infer that supermassive black holes indeed play a key role in how massive galaxies evolve, as well as the larger scale structures in the universe.” 

    Simulation modeling the evolution of a group of galaxies (left) and zooming in down to the nuclear region of the main galaxy (right), where the central supermassive black hole grows and affects its environment. (Photo courtesy of Daniel Anglés-Alcázar and the FIRE collaboration).

    Prior to joining UConn in 2019, Anglés-Alcázar was a research fellow with the Flatiron Institute from 2017 to 2019. In 2014, he was selected as a postdoctoral fellow with the Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) at Northwestern University. Most recently, he was one of 25 recipients of the 2023 Cottrell Scholar Awards from the Research Corporation for Science Advancement. 

    Anglés-Alcázar plans to use the funding to support student researchers, fund conference travel, and enhance computational resources for his work. 

    “Receiving this fellowship is really a great honor,” says Anglés-Alcázar. “I’m also very grateful to the students and postdocs in my group for the amazing work they do, and just excited that this award will enable us to continue pushing the frontiers of computational galaxy formation in new directions.” 

    MIL OSI USA News

  • MIL-OSI USA: UConn School of Business to Induct Five Distinguished Business Executives into ‘Hall of Fame’

    Source: US State of Connecticut

    The School of Business will induct five alumni business leaders into its ‘Hall of Fame’ during a dinner and ceremony on Friday, April 11 at the Hartford Marriott Downtown.

    The School’s signature event typically draws hundreds for a night of celebration.

    “This year, we proudly induct five exceptional alumni into the UConn School of Business Hall of Fame. Their remarkable achievements, leadership, and dedication to service place them among the most distinguished executives in their fields,’’ says Professor Greg Reilly, interim dean of the School of Business.

    “A highlight of the evening is hearing their reflections on their time at UConn and the invaluable advice they offer to students and young alumni,’’ he says. “The Hall of Fame celebration stands as one of the most inspiring and anticipated events of the year.”

    Tickets to the event, which is black-tie optional, are $175 each. There is still time to become an event sponsor as well. For reservations or additional information, please visit: alumni.business.uconn.edu.

    This year’s inductees include:

    Entrepreneur Trisha Bailey Believes in Exceptional Service

    Trisha Bailey, ’99 (CLAS) ’23 (HON) is an entrepreneur, and the founder and CEO of Bailey’s Pharmacy & Medical Equipment & Supplies, a company built on a culture of exceptional service. She oversees her flagship company, as well as other successful enterprises, employing more than 500 people and generating revenue in the hundreds of millions annually. She is also the mother of five.

    Tricia Bailey (contributed photo)

    Bailey graduated with a bachelor’s degree from UConn in 1999, majoring in human development and family relations, and received an honorary degree from the School of Pharmacy in 2023.

    A track standout at Weaver High School in Hartford, Bailey has been a generous donor to UConn Athletics and became the first woman to have a building named in her honor on campus. She is also involved in real estate development and housing; is a minority owner of NBA teams; and is the owner of the largest equestrian farm in Florida.

    A native of Jamaica, she is deeply committed to community impact, supporting underserved communities in her native land and in the U.S., supporting nursing programs, and food and toy drives.

    Her autobiography “UNBROKEN’’ addresses her complex life journey and shares her deeply held values of compassion, excellence, and empowerment.

    Laurie Havanec Led 300,000 Employees at CVS Health

    Laurie Havanec ’82 (BUS), ’94 JD recently retired from CVS Health, where she served as Executive Vice President and Chief People Officer. In that role, she was responsible for 300,000 employees. Prior to joining CVS, Havanec served as Executive Vice President and Chief People Officer at Otis Worldwide Corporation, including during its transition from United Technologies Corporation to an independent, publicly traded company.

    Laurie Havanec (contributed photo)

    Havanec earned her bachelor’s degree, with a marketing major, from the School of Business in 1982. Six weeks after the birth of her second child, she returned to UConn to fill her longtime desire to study law at the UConn Law School. She completed her degree with honors.

    In 2019, Havanec endowed a need-based scholarship, through UConn Women and Philanthropy, to help women in their path to law school. She has served on the Board of Directors of American Water, as a member of the Board of Trustees for both the Connecticut Women’s Hall of Fame and the Connecticut Governor’s Committee on Workforce and Education. A two-time cancer survivor, Havanec has told her story many times to help educate women about the importance of breast-cancer detection and prevention.

    Inclusivity Always Important to John Hodson

    John Hodson ’85 (BUS), is the Founder and President of True Benefit, a division of AmWINS, a company that goes beyond traditional employee benefits to foster a culture of inclusivity, ethical practices, and community engagement. The company’s mission is to serve both business and the broader community and he has championed diversity, equity, and belonging throughout his career.

    John Hodson (contributed photo)

    Hodson earned his bachelor’s degree, with a marketing major, in 1985 and worked at The Travelers and ConnectiCare. He then became an insurance broker and eventually founded True Benefit. Since its inception, the company has grown to become the exclusive program and risk manager for ADP Total Source, the largest professional employer organization in the nation. True Benefit now serves more than 750,000 employees nationwide, overseeing more than $4 billion in healthcare premiums and delivering healthcare savings and solutions for small- to mid- sized businesses.

    A dedicated advocate for LGBTQ+ rights and racial equity, Hodson has worked to improve insurance policies for the transgender community, addressing gaps in coverage and access to mental health care. He is also a proud supporter of UConn’s Name, Image, and Likeness (NIL) initiatives, with a focus on promoting mental health and the wellbeing of students. He is actively involved with several professional organizations and serves on the Board of Trustees at Sarah Lawrence College, which two of his children attended.

    Greg Lewis Served as SVP and CFO of Honeywell

    Greg Lewis ’91 (BUS) is the former Senior Vice President and CFO of Honeywell, a Fortune 100 company. This month, he will be stepping down from those roles and is serving as a special advisor to the CEO of the company, where he has worked since 2006.

    Greg Lewis (contributed photo)

    During his time at Honeywell, he served as a catalyst for digital transformation, launched the company’s Enterprise Information Management Strategy and made significant changes for greater operational excellence. He built a culture with data at the forefront of strategic decision making and provided critical leadership in response to the COVID-19 pandemic and the dynamic economic and geopolitical environment during the last five years.

    Lewis earned his bachelor’s degree from the School of Business in 1991, with a major in finance, and four years later earned an MBA from Fordham University.

    Over the last three years, Lewis has been involved with the School of Business,  engaging with faculty and students, and mentoring teams. Lewis is a champion of diversity and inclusion and is the executive sponsor of the All-Abilities Employee Network at Honeywell with over 2,500 associates. He chairs the Charlotte (NC) Small Business Innovation Fund and is a board member for Roof Above, a Charlotte-based organization fighting homelessness. He is also an independent director on the board of Medtronic.

    Lewis’ wife, Barbara, is a 1989 graduate of the School of Business. They have established a scholarship here, providing opportunities based on academic achievement and need.

    Rob Skinner Named a Top Financial Advisor

    Rob Skinner ’93 (CLAS) is a Founder and Managing Partner of IEQ Capital, an independent wealth management advisory firm which integrates investing and intellectual and emotional decisions.

    Robert Skinner (contributed photo)

    Skinner began his career at Fidelity Investments in 1995 and later joined Merrill Lynch as First Vice President of Investments. In 2008, he co-founded Luminous Capital, where he served as Chief Investment Officer, Co-Head of Investment Research, and Co-Manager of Portfolio Construction.  Luminous Capital managed $5.5 billion of assets when it was acquired by First Republic Bank in 2012. At First Republic, Skinner served as Senior Managing Director and Wealth Manager.

    Skinner has been lauded for his expertise, including being named as one of America’s Top Wealth Advisors by Forbes and as one of America’s Top 100 Financial Advisors by Barron’s.

    Skinner earned a bachelor’s degree from UConn in 1993, with a major in political science. He is active in a host of community programs, serving on the board of directors for The First Tee of Monterey County and also the Pebble Beach Company Foundation. He is a trustee of PGA REACH, the charitable arm of the PGA of America, as well as the Naval Postgraduate School Foundation, and serves on multiple investment advisory boards.

    MIL OSI USA News

  • MIL-OSI: Toobit Launches USDC-M Perpetual Contracts

    Source: GlobeNewswire (MIL-OSI)

    GEORGE TOWN, Cayman Islands, March 04, 2025 (GLOBE NEWSWIRE) — Toobit, the award-winning cryptocurrency derivatives exchange, today launches two new USDC-M Perpetual Contracts. Created to build greater price stability and capital efficiency on the trading platform, the product launch will begin with the flagship pairs, BTC/USDC and ETH/USDC.

    “As crypto markets mature, traders increasingly demand a more predictable margin system,” said Mike Williams, Chief Communication Officer of Toobit, “USDC perpetuals delivers on this need by minimizing exposure to potential fluctuations, making advanced trading strategies more accessible than ever.”

    By reducing exposure to collateral volatility, traders can manage risk more effectively on Toobit, while still accessing leverage of up to 175x.

    The crypto exchange also adopts transparent real-time PnL calculations and institutional-grade matching engines– platform features operating behind the scenes to ensure a seamless trading experience around the clock.

    USDC-M Perpetual Contracts, also known as USDC-M Perpetuals, are settled with USD Coin (USDC). Similar to USDT-M Perpetual Contracts, fees are typically settled between the long position holders and short position holders every 8 hours.

    To start trading, users simply need to transfer USDC to their derivatives account, navigate to the USDC Perpetual Contracts section, select their preferred leverage, and execute their positions. Fees can range from 0.02% for makers and 0.06% for takers.

    For more information on Perpetual Contracts, visit the Derivatives tab on http://www.toobit.com

    About Toobit

    Toobit is where the future of crypto trading unfolds—an award-winning cryptocurrency derivatives exchange built for those who thrive exploring new frontiers. With deep liquidity and cutting-edge technology, Toobit empowers traders worldwide to navigate the digital asset markets with confidence. We offer a fair, secure, seamless, and transparent trading experience, ensuring every trade is an opportunity to discover what’s next.

    For more information about Toobit, visit: WebsiteX | Telegram | LinkedIn | Discord | Instagram

    Contact: Davin C.

    Email: market@toobit.com

    Website: www.toobit.com

    Disclaimer: This content is provided by Toobit. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining and related opportunities involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector–including cryptocurrency, NFTs, and mining–complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release.

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/99598cab-c5c8-4c8a-8eb5-7ff63152d8c5

    The MIL Network

  • MIL-OSI: Bitfarms Announces Participation in Upcoming Investor and Industry Conferences

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, Ontario, March 04, 2025 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF), a global Bitcoin and vertically integrated data center company, today announced its participation in three upcoming investor and industry conferences.

    Investor Event Details:

    Event: Cantor Fitzgerald Global Technology Conference
    Date: March 12, 2025
    Location: New York, NY
    Bitfarms Participants: Ben Gagnon (CEO), Jeff Lucas (CFO), Tracy Krumme (SVP, IR & Comms)
    Panel Time: 3:40pm-4:05pm ET
    Panel Title: “Hybrid Model for Bitcoin Mining & AI”; CEO Ben Gagnon to participate

    Event: 37th Annual ROTH Conference
    Date: March 17-18, 2025
    Location: Dana Point, CA
    Bitfarms Participants: Liam Wilson (COO), Jeff Lucas (CFO), Tracy Krumme (SVP, IR & Comms)

    Industry Event Details:

    Event: NVIDIA GTC 2025
    Date: March 17-21, 2025
    Location: San Jose, CA
    Bitfarms Participants: Liam Wilson (COO), Philippe Fortier (EVP, Corporate Development), Alex Brammer (SVP, Mining Operations), Craig Hibbard (SVP, Infrastructure)

    For additional information or to schedule 1×1 meetings at any of the above conferences, please reach out to investors@bitfarms.com.

    About Bitfarms Ltd.

    Founded in 2017, Bitfarms is a global vertically integrated Bitcoin data center company that sells its computational power to one or more mining pools from which it receives payment in Bitcoin. Bitfarms develops, owns, and operates vertically integrated mining facilities with in-house management and company-owned electrical engineering, installation service, and multiple onsite technical repair centers.

    Bitfarms currently has 13 operating Bitcoin data centers, as well as hosting agreements with two data centers, in four countries: Canada, the United States, Paraguay, and Argentina. Powered predominantly by environmentally friendly hydro-electric and long-term power contracts, Bitfarms is committed to using sustainable and often underutilized energy infrastructure.

    To learn more about Bitfarms’ events, developments, and online communities:

    www.bitfarms.com
    https://www.facebook.com/bitfarms/
    https://twitter.com/Bitfarms_io
    https://www.instagram.com/bitfarms/
    https://www.linkedin.com/company/bitfarms/

    Investor Relations Contact:

    Bitfarms
    Tracy Krumme
    SVP, Head of IR & Corp. Comms.
    +1 786-671-5638
    tkrumme@bitfarms.com

    Media Contact: 

    Bitfarms
    Caroline Brady Baker 
    Director, Communications
    cbaker@bitfarms.com 

    The MIL Network

  • MIL-OSI: Next Hydrogen receives its ISO 9001 and ISO 45001 certifications

    Source: GlobeNewswire (MIL-OSI)

    MISSISSAUGA, Ontario, March 04, 2025 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (“Next Hydrogen“ or the “Company”) (TSXV:NXHOTC:NXHSF) is pleased to announce that it has received official ISO 9001-2015 and ISO 45001-2018 certification notices for its 6610 Edwards Blvd site in Mississauga, Canada. These certifications demonstrate and certify Next Hydrogen’s standardized quality systems, health and safety management systems, supplier selection processes, and continuous improvement processes.

    With these certifications Next Hydrogen has demonstrated that we have a robust operating system that can be scaled quickly to effectively support our growing customer base. Team Next Hydrogen is poised to exceed our customers’ expectations and become the supplier of choice for green hydrogen electrolysis systems. In 2024, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) provided a $2 million investment to Next Hydrogen which was critical in allowing Next Hydrogen to further enhance its quality standards and processes to help secure these certifications.

    “These important certifications highlight our team’s continued commitment and dedication to build our brand steeped in innovation, quality, safety and reliability”, said Raveel Afzaal, President & CEO. “We are particularly grateful to FedDev Ontario for their financial support to achieve this critical milestone as part of our scale-up activities.”

    “Congratulations to Next Hydrogen on this impressive milestone. Investments in clean technology companies, like Next Hydrogen, bolster Canada’s position as a global leader in green manufacturing and support our carbon reduction objectives,” said the Honourable Ruby Sahota, Minister of Democratic Institutions and Minister responsible for the Federal Economic Development Agency for Southern Ontario.

    About Next Hydrogen Solutions Inc.
    Founded in 2007, Next Hydrogen Solutions Inc. is a designer and manufacturer of water electrolyzers that use water and electricity as inputs to generate clean hydrogen for use as a green energy source or a green industrial feedstock. Next Hydrogen’s unique cell design architecture supported by 40 patents enables high current density operations and superior dynamic response to efficiently convert intermittent renewable electricity into green hydrogen on an infrastructure scale. Following successful pilots, Next Hydrogen is scaling up its technology to deliver commercial solutions to decarbonize transportation and industrial sectors. For further information: www.nexthydrogen.com

    About FedDev Ontario
    For 15 years, the Government of Canada, through FedDev Ontario, has worked to advance and diversify the southern Ontario economy through funding opportunities and business services that support innovation, growth and job creation in Canada’s most populous region. The Agency has delivered impressive results, which can be seen in southern Ontario businesses that are creating innovative technologies, improving productivity, growing revenues, creating jobs, and in the economic advancement of communities across the region. Learn more about the impacts the Agency is having in southern Ontario by exploring our investment profiles, our Southern Ontario Spotlight, and FedDev Ontario’s X, Facebook, Instagram and LinkedIn.

    Cautionary Statements
    This news release contains “forward-looking information” and “forward-looking statements”. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the risks associated with the hydrogen industry in general; delays or changes in plans with respect to infrastructure development or capital expenditures; the uncertainty of estimates and projections relating to costs and expenses; failure to obtain necessary regulatory approvals; health, safety and environmental risks; uncertainties resulting from potential delays or changes in plans with respect to infrastructure developments or capital expenditures; currency exchange rate fluctuations; as well as general economic conditions, stock market volatility; and the ability to access sufficient capital. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, there will be no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.

    The MIL Network

  • MIL-OSI: Aviva Canada: New data shows staggering rise in fraud across the country as Fraud Prevention Month kicks off

    Source: GlobeNewswire (MIL-OSI)

    • Aviva Canada data reveals a 76% rise in claim fraud investigations in 2024.
    • Auto-related incidents accounted for 67% of all claim fraud investigations during the past year.
    • Bad actors are capitalizing on Artificial Intelligence (AI) and technology for their malicious activities and Canadians are urged to keep vigilant.

    TORONTO, March 04, 2025 (GLOBE NEWSWIRE) — From auto theft to AI-generated documents and beyond, fraud continues to be one of the more pressing issues facing Canadian consumers and businesses in 2025.

    As Fraud Prevention Month kicks off, new data from Aviva Canada has revealed a 46% increase in claim fraud detection – and a staggering 76% rise in fraud investigations – in 2024. Auto-related incidents alone accounted for two-thirds (67%) of all claim fraud investigations during the past year. Advancements in AI and its use by individuals to falsify information are expected to be on the rise in 2025.

    “People are getting more sophisticated and innovative in their approaches when engaging in potentially fraudulent activity, making it increasingly difficult for the average Canadian to spot,” says Jamie Lee, Head of Financial Crime and Fraud, Aviva Canada. “Insurance fraud costs Canadians $1 billion per year in added premiums. It’s vital for Canadians to stay educated on the rising trends to better protect themselves.”

    Five Emerging Fraud Trends to Watch in 2025
    The methods used by bad actors are constantly evolving, so it’s important for Canadians to stay current on emerging trends. Aviva Canada’s data shows five types of fraud that are growing in the Canadian market:

    • Vehicle Theft and ReVINing – Vehicle thefts remain above pre-pandemic levels, with a 58% increase in investigations in the latter half of 2024. Stolen vehicles are often shipped overseas, or their VIN numbers altered and resold to unsuspecting Canadian buyers with false documentation. With the tightening of Canada-US borders, more stolen vehicles could remain in Canada, increasing the likelihood of Canadians buying a stolen vehicle from online public marketplaces.
    • Staged Auto Accidents – Increasing in numbers and complexity, staging false auto accidents is a trend on the rise across Canada. Aviva Canada saw a 47% increase in the number of staged accidents caught in Q4 2024. This type of scam could be linked to organized crime groups operating in Canada.
    • AI-Enabled Falsified or Forged Documents – The use of technology AI to edit or falsify documents is increasingly evident in investigations. This technology is frequently seen in both staged claims and opportunistic fraud, where it is used to create false claims or inflate legitimate claims, such as personal and commercial property contents claims, by supporting them with false invoices.
    • Ghost Brokers – People posing as licensed insurance brokers to sell fake policies or manipulate information to secure lower premiums is a growing concern in Canada, often leaving unsuspecting consumers without valid coverage. Consumers should be extra vigilant when purchasing insurance. They are encouraged to check their provincial registries to ensure the person they’re dealing with is properly licensed and confirm proof of insurance directly with the insurer.
    • Policy Misrepresentation – Individuals may misrepresent or omit key information from their insurance policies such as their true address, the intended use of a vehicle or property, or not disclosing major construction or renovations being done. These incidents can unfortunately lead to honest customers paying disproportionately higher premiums.

    “Fraud impacts Canadians not only financially, but also mentally and emotionally,” adds Lee. “Fraud costs everyone and drives up insurance premiums. At Aviva Canada, we are continuing to work with law enforcement and industry stakeholders to better protect Canadians from fraud.”

    For tips and more information on how to protect yourself or to report fraud, you can visit Aviva Canada’s Fraud Hub.

    Media Contact:
    Kelsie Ludlow
    Communications Specialist
    Tel: 437-331-7209
    Email: Kelsie.ludlow@aviva.com

    About Aviva Canada

    Aviva Canada is one of the leading property and casualty insurance groups in the country, providing home, automobile, lifestyle, and business insurance to 2.5 million customers coast to coast. A subsidiary of UK-based Aviva plc, we have the financial strength, scale and are a trusted insurance provider globally for more than 325 years.

    For more information, visit aviva.ca or Aviva Canada’s blogLinkedIn and Instagram pages.

    The MIL Network

  • MIL-OSI: Churchill Discovers Vanadium-Titanium-Iron Mineralization at the Taylor Brook Nickel Project, Newfoundland & Labrador

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, March 04, 2025 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to provide an update on its Taylor Brook nickel project where 2024 drilling and prospecting have returned anomalous Vanadium-Titanium-Magnetite (“VTM”) results at the TB-01 to TB-04 chargeability targets. These targets only cover a small area explored thus far on the margin of the large South Lobe of the Taylor Brook Gabbro Complex (“TBGC”), but suggest it to be a layered intrusion with critical minerals potential, in addition to the property’s high-grade magmatic Ni-Cu-Co mineralization seen at Layden (See news releases February 13, 2023, October 26, 2023).

    Mineralized magnetite-layered units sampled thus far at the South Lobe are generally several metres thick and gently dipping northeasterly, from which numerous 2024 samples returned anomalous values of 540ppm-955ppm V, 3.1%-7.29% Ti and >20% Fe with Ni, Cu and Co enrichment at several sites at the TB-01 Target (Fig. 1 and Table 1).   Winter Borehole Induced Polarization (“BHIP”) surveys at TB-01 have generated high chargeability off-hole targets in this same area, which will be drill tested along with a systematic trenching program.

    Highlights:

    • Taylor Brook Gabbro a layered intrusion with economic potential for VTM critical metals
    • Numerous enriched VTM layers outcrop at the South Lobe allowing systematic surface testing
    • Ni-Cu-Co sulphides found at/near surface at TB-01, also enriched in VTM mineralization
    • BHIP defines large, high chargeability targets near holes TB-24-42B and TB-24-43 at TB-01
    • Spring 2025 work plans include systematic trenching and more drilling at TB-01, and
    • Further exploration for both Ni-Cu-Co magmatic sulphides and VTM mineralization along strike from TB-01 and the ~10km2 magnetic/gravity anomaly at the South Lobe

    Paul Sobie, CEO, commented:

    “The anomalous VTM results we’re starting to see at TB-01 to 04, along with the associated shallow Ni-Cu-Co trends, are compelling, and systematic follow-up work will commence as soon as the snow cover melts. We prioritized this area based on anomalous Ni-Cu-Co in soils, and have drilled and prospected on surface the probable source layer within the TBGC, which is also anomalous in VTM’s, a good indication of layered intrusion-type mineral deposits. We’ve really only begun to evaluate a small portion of the overall approximately 10km2 magnetic / vanadium soil anomaly VTM target on the South Lobe and its margins, so our 2024 results are encouraging.

    VTM’s are important strategic metals for the steel, aerospace and battery industries for vanadium, and the pigment, steel and medical industries for titanium. North America has no vanadium production, with China, Russia, South Africa and Brazil the major producers, world-wide, from large layered intrusions such as the Bushveld Complex (South Africa). Layered intrusive mineral deposits typically exhibit layered VTM mineralization in the upper portions, with PGE and chromite deposits somewhat deeper, and Ni-Cu-Co-PGE deposits lowest, in the more ultramafic portion of the intrusion. The VTM mineralization intersected and prospected at surface at the TBGC therefore would appear to be at its upper levels, with exploration just getting started on the South Lobe.

    Figure 1 – Vanadium in rocks, soils and drill cores over South Lobe TMI with VTEM anomalies

    Systematic prospecting, mapping and trenching at the South Lobe, as well as more drilling at TB-01 are being planned. New exploration permit applications are being prepared for submittal. We’re quite excited by the BHIP method and results, which has located the highest chargeability targets within the TB-01 anomaly, off-hole but not distal from our 2024 drillholes. We’ll drill test these in 2025.”

    The South Lobe has been of particular interest to CRI since staking it in 2021 based on its intense magnetic signature and coincident gravity anomaly, more particularly now as it is returning anomalous vanadium and titanium soil survey and prospecting results per Figure 1. The South Lobe magnetic feature is predominantly a topographic high with good exposures of layering along its margins, where the VTM horizons are commonly resistive, outcropping or forming scarps. Presently less that 10% of the South Lobe has been prospected, therefore the Company is planning a comprehensive prospecting, mapping, and trenching/stripping program for the Spring. The TB-01 horizon(s) are laterally extensive based on airborne geophysics and soil sampling and will be followed up along strike in Spring 2025. As well, the Company’s exploration team will comprehensively sample holes TB-24-41, -42B and -43 for VTM mineralization and PGEs in order to test for potential deeper horizons of mineralization.

    Petrographic, lithogeochemical, and mineral liberation studies on mineralized samples are pending, which will assist in assessing the economic potential of these VTM units.

    Table 1 – Selected 2024 Assay and Lithogeochemical Samples Metal Analytical Results

    BHIP surveys at the TB-01 target were successful and have confirmed that off-hole chargeability anomalies correlate well with layers of VTM mineralization including a near-surface horizon also enriched in Ni-Cu-Co (see inset map on Figure 1). Hole TB-24-41 was blocked at 100m depth so the entire hole could not be surveyed, but the BHIP did detect the near-surface Ni-Cu-Co-VTM horizon (the Ni-Cu-Co trend on the figures) observed in the core as well as in numerous nearby angular boulders.

    The technical and scientific information in this news release has been reviewed and approved by Dr. Derek H.C Wilton, P.Geo., FGC, who is a “qualified person” as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”). Mr. Wilton is an honourary research professor of Economic Geology at Memorial University in St. John’s and is independent of the Company for the purposes of NI 43-101.

    The lithogeochemical samples reported here were whole rock pieces, collected from outcrop and historical drill core by Dr. Wilton during fieldwork in September/October 2024. These samples were sealed in labelled plastic bags in the field. All sample bags were photographed and transported to Thunder Bay, ON, by secure courier. The samples were analysed by ALS Geochemistry Ltd. in Thunder Bay using ME-ICP06 whole rock and ME-MS61L analytical protocols. Samples with over limit Ni contents were re-assayed using OG-46 Aqua-Regia overlimit method. Quality control results, including the laboratory’s own control samples, were evaluated immediately.

    The assay drill core and rock samples were placed in labelled, sealed plastic bags and delivered to Eastern Analytical of Springdale, NL, an ISO/IEC 17025 certified facility. The samples were analysed using ICP 34 (inductively coupled plasma) analytical protocols. Samples with over limit Ni and Fe contents were re-assayed using Eastern’s Ore Grade Assay (multi acid digestion) overlimit method. Quality control results, including the laboratory’s control samples, were evaluated immediately. 1

    1The Company reminds investors that surface rock samples are select samples and may not be representative of all mineralization on the Taylor Brook property.

    About Churchill Resources Inc.

    Churchill Resources Inc. is a Canadian exploration company focused on high grade, magmatic nickel sulphides in Canada, principally at its prospective Taylor Brook and Florence Lake properties in Newfoundland & Labrador. The Churchill management team, board and its advisors have decades of combined management experience in mineral exploration and in the establishment of successful publicly listed mining companies, both in Canada and around the world. Churchill’s Taylor Brook and Florence Lake projects have the potential to benefit from the province’s large and diversified minerals industry, which includes world class nickel mines and processing facilities, and a well-developed mineral exploration sector with locally based drilling and geological expertise.

    Further Information

    For further information regarding Churchill, please contact:

    Churchill Resources Inc.   
    Paul Sobie, Chief Executive Officer   
    Tel. +1 416.365.0930 (o)  
      +1 647.988.0930 (m)  
    Email psobie@churchillresources.com  
         
    Alec Rowlands, Corporate Consultant   
    Tel. +1 416.721.4732 (m)  
    Email arowlands@churchillresources.com  
         

    Cautionary Note Regarding Forward Looking Information

    This news release contains “forward-looking information” and “forward-looking statements” (collectively, forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “proposed”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, , the Company’s objectives, goals and exploration activities conducted and proposed to be conducted at the Company’s properties; interpretation of recent exploration results; future growth potential of the Company, including whether any proposed exploration programs at any of the Company’s properties will be successful; exploration results; and future exploration plans and costs and financing availability.

    These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: the expected benefits to the Company relating to the exploration conducted and proposed to be conducted at the Company’s properties; failure to identify any mineral resources or significant mineralization; the preliminary nature of metallurgical test results; uncertainties relating to the availability and costs of financing needed in the future, including to fund any exploration programs on the Company’s properties; fluctuations in general macroeconomic conditions; fluctuations in securities markets; fluctuations in spot and forward prices of gold, silver, base metals or certain other commodities; fluctuations in currency markets (such as the Canadian dollar to United States dollar exchange rate); change in national and local government, legislation, taxation, controls, regulations and political or economic developments; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected formations pressures, cave-ins and flooding); inability to obtain adequate insurance to cover risks and hazards; the presence of laws and regulations that may impose restrictions on mining and mineral exploration; employee relations; relationships with and claims by local communities and indigenous populations; availability of increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development (including the risks of obtaining necessary licenses, permits and approvals from government authorities); the unlikelihood that properties that are explored are ultimately developed into producing mines; geological factors; actual results of current and future exploration; changes in project parameters as plans continue to be evaluated; soil sampling results being preliminary in nature and are not conclusive evidence of the likelihood of a mineral deposit; title to properties; and those factors described in the most recently filed management’s discussion and analysis of the Company. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements and information. There can be no assurance that forward-looking information, or the material factors or assumptions used to develop such forward-looking information, will prove to be accurate. The Company does not undertake to release publicly any revisions for updating any voluntary forward-looking statements, except as required by applicable securities law.

    Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

    Photos accompanying this announcement are available at: 

    https://www.globenewswire.com/NewsRoom/AttachmentNg/f88f1c38-2fc8-4687-b536-67baa68ec31e

    https://www.globenewswire.com/NewsRoom/AttachmentNg/0d18ace1-d149-45eb-b87f-bf7a1d931b09

    The MIL Network

  • MIL-OSI Africa: Pepfar funding to fight HIV/Aids has saved 26 million lives since 2003: how cutting it will hurt Africa

    Source: The Conversation – Africa – By Eric Friedman, Researcher, Georgetown University

    The US President’s Emergency Plan for AIDS Relief has been a cornerstone of global HIV/Aids prevention, care and treatment for over two decades. Pepfar has enjoyed broad bipartisan support in the US, but its future is now uncertain. Public health scholars Eric A. Friedman, Sarah A. Wetter and Lawrence O. Gostin explain Pepfar’s history and impacts, as well as what may lie ahead.

    The early years

    Many people today have forgotten the sheer devastation that the Aids pandemic wrought on the African continent, first spreading widely in east Africa in the 1980s. By the end of the 20th century, life expectancy in the region had decreased from 64 to 47 years.

    Millions of children were infected and many grew up as orphans, with HIV taking the life of one or both of their parents. Children, especially girls, were taken out of school to nurse sick relatives or because school fees were unaffordable.

    Underfunded health systems were near collapse, as were the economies of many African countries.

    Infection rates in several countries on the continent topped 30% of their adult populations.

    These devastating figures persisted despite the discovery of highly effective antiretroviral therapies in the 1990s. These drugs rapidly became widely available in rich countries, beginning in 1996, leading to an 84% decline in death rates over four years.

    But cost kept the drugs out of reach for African countries.

    Only about 100,000 of the 20 million people infected with HIV in Africa were accessing drug treatment in 2003.

    The turnaround

    A major breakthrough came when US president George W Bush proposed a bold global initiative, Pepfar, in his 2003 State of the Union Address. Pepfar would dedicate US$15 billion over five years with the goals of preventing 7 million new infections, treating 2 million people, and caring for another 10 million infected with HIV or orphaned by the disease.

    By 2005, more than 800,000 people were being treated for HIV in Africa – an eightfold increase from only two years prior. Under Pepfar, the costs of antiretroviral treatment per person per year in low- and middle-income countries fell from US$1,200 in 2003 to just US$58 in 2023.

    Pepfar maintained bipartisan support throughout both Democratic and Republican-led administrations and Congresses. Through 2018, it had been reauthorised three times, each for five years.

    The programme has lived up to its promise. The investment of over US$110 billion since being launched has been transformative, with sub-Saharan Africa benefiting the most.

    Globally, Pepfar has saved 26 million lives and prevented nearly 8 million babies from being born with HIV. In 2024, more than 20 million people were receiving HIV treatment through Pepfar, which was also supporting well over 6 million orphans, vulnerable children and their caregivers, and enabled nearly 84 million people to be tested for HIV that year.

    Its importance extends beyond Aids. The programme directly supports more than 340,000 health workers, a tremendous contribution in Africa especially, given severe health worker shortages in much of the continent.

    Pepfar-supported health services integrate HIV services with tuberculosis care, treatment and prevention. And since 2019, Pepfar has been part of a partnership for screening and treating women with HIV for cervical cancer, focused on 12 high-burden countries in sub-Saharan Africa.

    But the past two years have been ones of political discord and major disruption.

    Troubles begin

    The trouble began in May 2023, with Pepfar due for a five-year reauthorisation.

    A key member of Congress, along with organisations against abortion, raised concerns that Pepfar was supporting abortions, even though there was no such evidence at the time. In fact, by law Pepfar is prohibited from supporting abortions.

    House Republicans sought to include abortion restrictions in the Pepfar reauthorisation. But Congress passed a reauthorisation bill without abortion provisions in March 2024, to last until 25 March 2025.

    Ever since then, the threats posed to a five-year Pepfar reauthorisation have grown.

    The Trump effect

    In January, Pepfar reported to Congress that its own investigators had found that four nurses in Mozambique had used Pepfar funding to perform abortions (which are legal in Mozambique), 21 in all. Pepfar officials froze funds to the four nurses and required staff to attest to understanding that they were prohibited from providing abortion as part of US-funded health services.

    Days later Pepfar, along with most other US foreign assistance programmes, suffered a severe blow. President Donald Trump signed an executive order pausing all further disbursements and new obligations of foreign assistance funds for 90 days, pending a sweeping review.

    Four days later, secretary of state Marco Rubio issued a directive that went even further, also requiring organisations to stop work, even those that had already received funds needed to operate.

    By 27 January, virtually all US foreign assistance programmes had come to a halt, including Pepfar programmes.

    Following an outcry, Rubio issued a waiver for lifesaving humanitarian assistance on 28 January. With confusion over what was covered, including whether the waiver encompassed HIV medicines, he issued another waiver on 1 February, covering Pepfar treatment and care programmes, including prevention of and treatment for TB and other opportunistic infections, as well as prevention of mother-to-child transmission programmes.

    But organisations receiving US foreign assistance funds needed to get individual approval to resume, and the administration had put much of USAid’s staff on administrative leave. USAid (along with the US Centers for Disease Control and Prevention) has a central role in administering Pepfar. Many others, including contractors embedded in USAid operations, have been furloughed or fired.

    Very few people existed to process requests to resume work. Furthermore, USAid’s payment system appeared not to be working.

    The decisions of the Trump administration are being challenged in court in the US on the grounds that they are illegal and unconstitutional because they are usurping Congress’s power to determine how the US government spends funds, among other violations of the law.

    Nonetheless, as of this writing, despite a court order to resume funding, it remains entirely frozen, and most programmes are still shut down. The day after the court ordered the government to pay nearly US$2 billion it owes organisations for work already done, the administration revealed that it had terminated the vast majority of foreign assistance awards, including some for Pepfar. Details have not been made public. Meanwhile, the US Supreme Court put a short-term pause on the lower court’s order to immediately pay the money already owed.

    The impact

    The impact has been immediate. People on HIV treatment could not pick up additional medicine, leading to treatment interruption. Pepfar-funded health services had to turn away patients. Health workers supported by Pepfar, among them 40,000 in Kenya, could no longer be paid.

    Many organisations that relied on Pepfar funds also had to lay off staff. Community groups have been affected and many have suspended their services entirely.

    It remains unclear what the future holds – how severe the cuts will be, and to what programmes. In the near term, much depends on the courts and whether the administration implements court orders, as it has yet to do. In the longer term, Congress could seek to resume Pepfar to its former strength, though this would mean acting against the administration’s wishes. Even then, it is not clear whether the administration would spend the money allocated, and the damage already done to Pepfar programmes and trust in the US government will not be repaired quickly.

    Pepfar is currently funded at US$7.5 billion annually. It accounts for over 10% of all US foreign assistance and over half of US global health assistance.

    The separate Pepfar waiver suggests the deepest support for Pepfar is for HIV treatment programmes, as well as others meant to be protected under the waiver. Barring vast cuts to foreign assistance and Pepfar, these programmes are most likely to be at least spared, though the administration has terminated even some grants that had been covered by the waiver.

    Other Pepfar programmes, particularly with respect to HIV prevention, are most vulnerable.

    Rethinking priorities

    The vulnerability of different African countries to Pepfar cuts varies widely. Some fund most of their own HIV programmes. South Africa’s HIV programmes are 74% domestically funded, with the balance coming from Pepfar (17%) and the Global Fund (7%).

    But Pepfar funding accounts for about 90% of all HIV funding in Tanzania and Côte d’Ivoire, and more than half of HIV medicines purchased for the Democratic Republic of Congo, Mozambique and Zambia are purchased by the US.

    If there are significant Pepfar funding cuts, it is doubtful that other wealthy countries will be able to compensate. And because the US, through Pepfar, is the largest contributor to the Global Fund, it is unlikely that the Global Fund could fill the gap either.

    Under these circumstances, unless countries increase their domestic HIV spending, the dramatic progress in combating HIV/Aids in Africa could begin to become undone.
    The conversation in Africa must focus on ending reliance on foreign assistance and developing resilient financing mechanisms to continue the fight to end Aids.

    – Pepfar funding to fight HIV/Aids has saved 26 million lives since 2003: how cutting it will hurt Africa
    – https://theconversation.com/pepfar-funding-to-fight-hiv-aids-has-saved-26-million-lives-since-2003-how-cutting-it-will-hurt-africa-250413

    MIL OSI Africa

  • MIL-OSI: Notice of annual general meeting 2024

    Source: GlobeNewswire (MIL-OSI)

    To Nasdaq OMX Copenhagen
    4 March 2025
    Company announcement no. 3/2025

    Notice of annual general meeting in the BANK of Greenland A/S

    The BANK of Greenland A/S will hold its annual general meeting on Wednesday 26 March 2025 at 4pm (UTC -2) as an electronic annual general meeting with the possibility to participate physically at the BANK of Greenland’s head office in Nuuk.

    The agenda is included in the attached file.

    Best regards
    The BANK of Greenland

    Martin Kviesgaard
    Managing Director

    Contact: +299 34 78 02 / mail: mbk@banken.gl

    Attachment

    The MIL Network

  • MIL-OSI Global: Pepfar funding to fight HIV/Aids has saved 26 million lives since 2003: how cutting it will hurt Africa

    Source: The Conversation – Africa – By Eric Friedman, Researcher, Georgetown University

    The US President’s Emergency Plan for AIDS Relief has been a cornerstone of global HIV/Aids prevention, care and treatment for over two decades. Pepfar has enjoyed broad bipartisan support in the US, but its future is now uncertain. Public health scholars Eric A. Friedman, Sarah A. Wetter and Lawrence O. Gostin explain Pepfar’s history and impacts, as well as what may lie ahead.

    The early years

    Many people today have forgotten the sheer devastation that the Aids pandemic wrought on the African continent, first spreading widely in east Africa in the 1980s. By the end of the 20th century, life expectancy in the region had decreased from 64 to 47 years.

    Millions of children were infected and many grew up as orphans, with HIV taking the life of one or both of their parents. Children, especially girls, were taken out of school to nurse sick relatives or because school fees were unaffordable.

    Underfunded health systems were near collapse, as were the economies of many African countries.

    Infection rates in several countries on the continent topped 30% of their adult populations.

    These devastating figures persisted despite the discovery of highly effective antiretroviral therapies in the 1990s. These drugs rapidly became widely available in rich countries, beginning in 1996, leading to an 84% decline in death rates over four years.

    But cost kept the drugs out of reach for African countries.

    Only about 100,000 of the 20 million people infected with HIV in Africa were accessing drug treatment in 2003.

    The turnaround

    A major breakthrough came when US president George W Bush proposed a bold global initiative, Pepfar, in his 2003 State of the Union Address. Pepfar would dedicate US$15 billion over five years with the goals of preventing 7 million new infections, treating 2 million people, and caring for another 10 million infected with HIV or orphaned by the disease.

    By 2005, more than 800,000 people were being treated for HIV in Africa – an eightfold increase from only two years prior. Under Pepfar, the costs of antiretroviral treatment per person per year in low- and middle-income countries fell from US$1,200 in 2003 to just US$58 in 2023.

    Pepfar maintained bipartisan support throughout both Democratic and Republican-led administrations and Congresses. Through 2018, it had been reauthorised three times, each for five years.

    The programme has lived up to its promise. The investment of over US$110 billion since being launched has been transformative, with sub-Saharan Africa benefiting the most.

    Globally, Pepfar has saved 26 million lives and prevented nearly 8 million babies from being born with HIV. In 2024, more than 20 million people were receiving HIV treatment through Pepfar, which was also supporting well over 6 million orphans, vulnerable children and their caregivers, and enabled nearly 84 million people to be tested for HIV that year.

    Its importance extends beyond Aids. The programme directly supports more than 340,000 health workers, a tremendous contribution in Africa especially, given severe health worker shortages in much of the continent.

    Pepfar-supported health services integrate HIV services with tuberculosis care, treatment and prevention. And since 2019, Pepfar has been part of a partnership for screening and treating women with HIV for cervical cancer, focused on 12 high-burden countries in sub-Saharan Africa.

    But the past two years have been ones of political discord and major disruption.

    Troubles begin

    The trouble began in May 2023, with Pepfar due for a five-year reauthorisation.

    A key member of Congress, along with organisations against abortion, raised concerns that Pepfar was supporting abortions, even though there was no such evidence at the time. In fact, by law Pepfar is prohibited from supporting abortions.

    House Republicans sought to include abortion restrictions in the Pepfar reauthorisation. But Congress passed a reauthorisation bill without abortion provisions in March 2024, to last until 25 March 2025.

    Ever since then, the threats posed to a five-year Pepfar reauthorisation have grown.

    The Trump effect

    In January, Pepfar reported to Congress that its own investigators had found that four nurses in Mozambique had used Pepfar funding to perform abortions (which are legal in Mozambique), 21 in all. Pepfar officials froze funds to the four nurses and required staff to attest to understanding that they were prohibited from providing abortion as part of US-funded health services.

    Days later Pepfar, along with most other US foreign assistance programmes, suffered a severe blow. President Donald Trump signed an executive order pausing all further disbursements and new obligations of foreign assistance funds for 90 days, pending a sweeping review.

    Four days later, secretary of state Marco Rubio issued a directive that went even further, also requiring organisations to stop work, even those that had already received funds needed to operate.

    By 27 January, virtually all US foreign assistance programmes had come to a halt, including Pepfar programmes.

    Following an outcry, Rubio issued a waiver for lifesaving humanitarian assistance on 28 January. With confusion over what was covered, including whether the waiver encompassed HIV medicines, he issued another waiver on 1 February, covering Pepfar treatment and care programmes, including prevention of and treatment for TB and other opportunistic infections, as well as prevention of mother-to-child transmission programmes.

    But organisations receiving US foreign assistance funds needed to get individual approval to resume, and the administration had put much of USAid’s staff on administrative leave. USAid (along with the US Centers for Disease Control and Prevention) has a central role in administering Pepfar. Many others, including contractors embedded in USAid operations, have been furloughed or fired.

    Very few people existed to process requests to resume work. Furthermore, USAid’s payment system appeared not to be working.

    The decisions of the Trump administration are being challenged in court in the US on the grounds that they are illegal and unconstitutional because they are usurping Congress’s power to determine how the US government spends funds, among other violations of the law.

    Nonetheless, as of this writing, despite a court order to resume funding, it remains entirely frozen, and most programmes are still shut down. The day after the court ordered the government to pay nearly US$2 billion it owes organisations for work already done, the administration revealed that it had terminated the vast majority of foreign assistance awards, including some for Pepfar. Details have not been made public. Meanwhile, the US Supreme Court put a short-term pause on the lower court’s order to immediately pay the money already owed.

    The impact

    The impact has been immediate. People on HIV treatment could not pick up additional medicine, leading to treatment interruption. Pepfar-funded health services had to turn away patients. Health workers supported by Pepfar, among them 40,000 in Kenya, could no longer be paid.

    Many organisations that relied on Pepfar funds also had to lay off staff. Community groups have been affected and many have suspended their services entirely.

    It remains unclear what the future holds – how severe the cuts will be, and to what programmes. In the near term, much depends on the courts and whether the administration implements court orders, as it has yet to do. In the longer term, Congress could seek to resume Pepfar to its former strength, though this would mean acting against the administration’s wishes. Even then, it is not clear whether the administration would spend the money allocated, and the damage already done to Pepfar programmes and trust in the US government will not be repaired quickly.

    Pepfar is currently funded at US$7.5 billion annually. It accounts for over 10% of all US foreign assistance and over half of US global health assistance.

    The separate Pepfar waiver suggests the deepest support for Pepfar is for HIV treatment programmes, as well as others meant to be protected under the waiver. Barring vast cuts to foreign assistance and Pepfar, these programmes are most likely to be at least spared, though the administration has terminated even some grants that had been covered by the waiver.

    Other Pepfar programmes, particularly with respect to HIV prevention, are most vulnerable.

    Rethinking priorities

    The vulnerability of different African countries to Pepfar cuts varies widely. Some fund most of their own HIV programmes. South Africa’s HIV programmes are 74% domestically funded, with the balance coming from Pepfar (17%) and the Global Fund (7%).

    But Pepfar funding accounts for about 90% of all HIV funding in Tanzania and Côte d’Ivoire, and more than half of HIV medicines purchased for the Democratic Republic of Congo, Mozambique and Zambia are purchased by the US.

    If there are significant Pepfar funding cuts, it is doubtful that other wealthy countries will be able to compensate. And because the US, through Pepfar, is the largest contributor to the Global Fund, it is unlikely that the Global Fund could fill the gap either.

    Under these circumstances, unless countries increase their domestic HIV spending, the dramatic progress in combating HIV/Aids in Africa could begin to become undone.
    The conversation in Africa must focus on ending reliance on foreign assistance and developing resilient financing mechanisms to continue the fight to end Aids.

    Lawrence O. Gostin is Director of the WHO Collaborating Center on Global Health Law

    Eric Friedman and Sarah Wetter do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

    ref. Pepfar funding to fight HIV/Aids has saved 26 million lives since 2003: how cutting it will hurt Africa – https://theconversation.com/pepfar-funding-to-fight-hiv-aids-has-saved-26-million-lives-since-2003-how-cutting-it-will-hurt-africa-250413

    MIL OSI – Global Reports

  • MIL-Evening Report: ‘Back off AUKUS’, Greens MP Tuiono warns NZ in wake of Trump row

    Asia Pacific Report

    The Green Party has called on Prime Minister Christopher Luxon to rule out Aotearoa New Zealand joining the AUKUS military technical pact in any capacity following the row over Ukraine in the White House over the weekend.

    President Donald Trump’s “appalling treatment” of his Ukrainian counterpart Volodymyr Zelenskyy was a “clear warning that we must avoid AUKUS at all costs”, said Green Party foreign affairs and Pacific issues spokesperson Teanau Tuiono.

    “Aotearoa must stand on an independent and principled approach to foreign affairs and use that as a platform to promote peace.”

    US President Donald Trump has paused all military aid for Ukraine after the “disastrous” Oval Office meeting with President Zelenskyy in another unpopular foreign affairs move that has been widely condemned by European leaders.

    Oleksandr Merezhko, the chair of Ukraine’s Parliamentary Foreign Affairs Committee, declared that Trump appeared to be trying to push Kyiv to capitulate on Russia’s terms.

    He was quoted as saying that the aid pause was worse than the 1938 Munich Agreement that allowed Nazi Germany to annex part of Czechoslovakia.

    ‘Danger of Trump leadership’
    Tuiono, who is the Green Party’s first tagata moana MP, said: “What we saw in the White House at the weekend laid bare the volatility and danger of the Trump leadership — nothing good can come from deepening our links to this administration.

    “Christopher Luxon should read the room and rule out joining any part of the AUKUS framework.”

    Tuiono said New Zealand should steer clear of AUKUS regardless of who was in the White House “but Trump’s transactional and hyper-aggressive foreign policy makes the case to stay out stronger than ever”.

    “Our country must not join a campaign that is escalating tensions in the Pacific and talking up the prospects of a war which the people of our region firmly oppose.

    “Advocating for, and working towards, peaceful solutions to the world’s conflicts must be an absolute priority for our country,” Tuiono said.

    Five Eyes network ‘out of control’
    Meanwhile, in the 1News weekly television current affairs programme Q&A, former Prime Minister Helen Clark challenged New Zealand’s continued involvement in the Five Eyes intelligence network, describing it as “out of control”.

    Her comments reflected growing concern by traditional allies and partners of the US over President Trump’s handling of long-standing relationships.

    Clark said the Five Eyes had strayed beyond its original brief of being merely a coordinating group for intelligence agencies in the US, Canada, UK, Australia, and New Zealand.

    “There’s been some talk in the media that Trump might want to evict Canada from it . . . Please could we follow?” she said.

    “I mean, really, the problem with Five Eyes now has become a basis for policy positioning on all sorts of things.

    “And to see it now as the basis for joint statements, finance minister meetings, this has got a bit out of control.”

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI: Radware to Host its Hackers Challenge in Peru

    Source: GlobeNewswire (MIL-OSI)

    MAHWAH, N.J., March 04, 2025 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, announced it is holding its Hackers Challenge on March 13, 2025, in Lima, Peru at the Westin Lima Hotel and Convention Center. The flagship event, which brings together global security and technology experts from the private and public sector, will combine learning, collaboration and innovation to help companies solve their most pressing cybersecurity issues.

    According to Piero Garmendia, Radware’s regional manager for the South of Latin America region, “Radware’s Hackers Challenge offers organizations a unique opportunity to watch hackers in live action and then apply that learning in strengthening their own cyber defense strategies. We are convinced the simulation will serve as a key platform to inspire ideas and prepare security professionals for the cyber challenges of the future.”

    During the event, hackers will go head-to-head with Radware’s security experts and web application and API protection defenses, trying to breach protected web applications by circumventing tools designed to block their malicious attempts. While witnessing the hackers’ techniques, the live audience will learn corresponding protection strategies.

    In addition, participants will learn how artificial intelligence can be used to manage security vulnerabilities across corporate networks. They also will get firsthand insights from a panel of cybersecurity and digital transformation experts representing government offices and leading financial institutions from Peru as well as an international embassy.

    “In a world that is becoming more inter-connected, cybersecurity is a fundamental pillar for progress,” said Arie Simchis, Radware’s regional director in Latin America. “Our event reflects Radware’s leadership and ongoing commitment to cybersecurity innovation in the region. Operating for nearly 20 years in Latin America, we intend to continue to play a major role in strengthening cybersecurity capabilities and increasing technological resilience across the region.”

    Radware’s Latin American presence spans Argentina, Bolivia, Brazil, Chile, Columbia, Ecuador, Mexico, Panama, and Peru. In addition, the company has cloud security service centers in Chile and Brazil. The Latin American facilities are part of Radware’s worldwide network of over 50 cloud security service centers, which offer a combined mitigation capacity of 15Tbps. The company plans to continue to grow its global footprint, opening more cloud security service centers in 2025.

    Visit Radware’s Hackers Challenge website for more information.

    About Radware
    Radware® (NASDAQ: RDWR) is a global leader in application security and delivery solutions for multi-cloud environments. The company’s cloud application, infrastructure, and API security solutions use AI-driven algorithms for precise, hands-free, real-time protection from the most sophisticated web, application, and DDoS attacks, API abuse, and bad bots. Enterprises and carriers worldwide rely on Radware’s solutions to address evolving cybersecurity challenges and protect their brands and business operations while reducing costs. For more information, please visit the Radware website.

    Radware encourages you to join our community and follow us on: Facebook, LinkedIn, Radware Blog, X, YouTube, and Radware Mobile for iOS.

    ©2025 Radware Ltd. All rights reserved. Any Radware products and solutions mentioned in this press release are protected by trademarks, patents, and pending patent applications of Radware in the U.S. and other countries. For more details, please see: https://www.radware.com/LegalNotice/. All other trademarks and names are property of their respective owners.

    Radware believes the information in this document is accurate in all material respects as of its publication date. However, the information is provided without any express, statutory, or implied warranties and is subject to change without notice.

    The contents of any website or hyperlinks mentioned in this press release are for informational purposes and the contents thereof are not part of this press release.

    Safe Harbor Statement
    This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements made herein that are not statements of historical fact, including statements about Radware’s plans, outlook, beliefs, or opinions, are forward-looking statements. Generally, forward-looking statements may be identified by words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could.” For example, when we say in this press release that we intend to continue to play a major role in strengthening cybersecurity capabilities and increasing technological resilience across the region, we are using forward-looking statements. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results, expressed or implied by such forward-looking statements, could differ materially from Radware’s current forecasts and estimates. Factors that could cause or contribute to such differences include, but are not limited to: the impact of global economic conditions, including as a result of the state of war declared in Israel in October 2023 and instability in the Middle East, the war in Ukraine, and the tensions between China and Taiwan; our dependence on independent distributors to sell our products; our ability to manage our anticipated growth effectively; a shortage of components or manufacturing capacity could cause a delay in our ability to fulfill orders or increase our manufacturing costs; our business may be affected by sanctions, export controls, and similar measures, targeting Russia and other countries and territories, as well as other responses to Russia’s military conflict in Ukraine, including indefinite suspension of operations in Russia and dealings with Russian entities by many multi-national businesses across a variety of industries; the ability of vendors to provide our hardware platforms and components for the manufacture of our products; our ability to attract, train, and retain highly qualified personnel; intense competition in the market for cyber security and application delivery solutions and in our industry in general, and changes in the competitive landscape; our ability to develop new solutions and enhance existing solutions; the impact to our reputation and business in the event of real or perceived shortcomings, defects, or vulnerabilities in our solutions, if our end-users experience security breaches, if our information technology systems and data, or those of our service providers and other contractors, are compromised by cyber-attackers or other malicious actors or by a critical system failure; outages, interruptions, or delays in hosting services; the risks associated with our global operations, such as difficulties and costs of staffing and managing foreign operations, compliance costs arising from host country laws or regulations, partial or total expropriation, export duties and quotas, local tax exposure, economic or political instability, including as a result of insurrection, war, natural disasters, and major environmental, climate, or public health concerns, such as the COVID-19 pandemic; our net losses in the past two years and possibility we may incur losses in the future; a slowdown in the growth of the cyber security and application delivery solutions market or in the development of the market for our cloud-based solutions; long sales cycles for our solutions; risks and uncertainties relating to acquisitions or other investments; risks associated with doing business in countries with a history of corruption or with foreign governments; changes in foreign currency exchange rates; risks associated with undetected defects or errors in our products; our ability to protect our proprietary technology; intellectual property infringement claims made by third parties; laws, regulations, and industry standards affecting our business; compliance with open source and third-party licenses; and other factors and risks over which we may have little or no control. This list is intended to identify only certain of the principal factors that could cause actual results to differ. For a more detailed description of the risks and uncertainties affecting Radware, refer to Radware’s Annual Report on Form 20-F, filed with the Securities and Exchange Commission (SEC), and the other risk factors discussed from time to time by Radware in reports filed with, or furnished to, the SEC. Forward-looking statements speak only as of the date on which they are made and, except as required by applicable law, Radware undertakes no commitment to revise or update any forward-looking statement in order to reflect events or circumstances after the date any such statement is made. Radware’s public filings are available from the SEC’s website at www.sec.gov or may be obtained on Radware’s website at www.radware.com.

    Media Contacts:
    Gerri Dyrek
    Radware
    Gerri.Dyrek@radware.com

    The MIL Network

  • MIL-OSI USA: Sols 4468-4470: A Wintry Mix of Mars Science

    Source: NASA

    Written by Lucy Lim, Planetary Scientist at NASA’s Goddard Space Flight Center

    Earth planning date: Friday, Feb. 28, 2025
    Curiosity continues to climb roughly southward through the layered sulfate strata toward the “boxwork” features. Although the previous plan’s drive successfully advanced the rover roughly 21 meters southward (about 69 feet), the drive had ended with an awkwardly perched wheel. Because of this, unfortunately it was considered too risky to unstow the arm for contact science in this plan.
    Nevertheless the team made the most of the imaging and LIBS observations available from the rover’s current location. A large Mastcam mosaic was planned on the nearby Texoli butte to capture its sedimentary structures from the rover’s new perspective. Toward the west, the boxwork strata exposed on “Gould Mesa” were observed using the ChemCam long-distance imaging capability, with Mastcam providing color context.
    Several near-field Mastcam mosaics also captured some bedding and diagenetic structure in the nearby blocks as well as some modern aeolian troughs in the finer-grained material around them.
    On the nearby blocks, two representative local blocks (“Gabrelino Trail” and “Sespe Creek”) are to be “zapped” with the ChemCam laser to give us LIBS (laser-induced breakdown spectroscopy) compositional measurements. The original Gabrelino Trail on Earth near the JPL campus is currently closed due to damage from the recent wildfires.
    Meanwhile, the season on Mars (L_s ~ 50, or a solar longitude of about 50 degrees, heading into southern winter) has brought with it the opportunity to observe some recurring atmospheric phenomena: It’s aphelion cloud belt season, as well as Hadley cell transition season, during which a more southerly air mass crosses over Gale Crater. 
    This plan includes an APXS atmospheric observation (no arm movement required!) to measure argon and a ChemCam passive-sky observation to measure O2, which is a small (less than 1%) but measurable component in the Martian atmosphere. Dedicated cloud altitude observations, a phase function sky survey, and zenith and suprahorizon movies have also been included in the plan to characterize the clouds. As usual, the rover also continues to monitor the modern environment with measurements of atmospheric opacity via imaging, temperature, and humidity with REMS, and the local neutron environment with DAN.

    MIL OSI USA News

  • MIL-OSI USA: My Dog Has Cancer: What Do I Need to Know?

    Source: US Food and Drug Administration

    [embedded content]

     
    Any pet owner who has been told their animal has cancer knows the two emotions: anxiety for the beloved pet’s life, and hope for an effective treatment.
    “Many people consider their dogs and cats members of the family,” says Food and Drug Administration veterinarian Lisa Troutman. “Just as the FDA reviews drugs for humans for safety and effectiveness before they can go on the market, the agency does the same for treatments for animals.”
    Take, for instance, cancer, which accounts for almost half of the deaths of pets over 10 years of age. Although pets of any age can have cancer, the longer they live, the greater the likelihood of developing it. Dogs get cancer at roughly the same rate as humans.
    “Pets are living longer because of preventative health care. And we’re able to diagnose cancers earlier. As a result there is an increased need for better cancer treatments,” Troutman notes.
    Until very recently, the only drugs available to treat cancer in animals were those approved for use in humans. But in the last few years, veterinary drug sponsors (the pharmaceutical companies developing the drugs) have brought to market treatments meant specifically for animals.
    Troutman explains, “the FDA works closely with these companies to discuss how they can demonstrate that their innovative veterinary drugs are safe and effective, and to address questions that arise while working toward approval of their drug.”
    FDA Evaluates Safety and Effectiveness of Medicines
    To evaluate the safety of any new veterinary drug, companies typically conduct a study in a small number of healthy animals in the same species that the drug is intended for. For example, if the drug is for dogs, it will be tried first in healthy dogs. The findings help the veterinarian anticipate potential side effects when the drug is used to treat a patient and help minimize adverse events that might affect the pet’s quality of life.
    Companies also must show in controlled studies that the drug works — that it is effective when used according to the label. For example, for a drug intended for a particular kind of cancer, companies typically run a clinical trial at multiple animal hospitals where pets are being treated for that cancer. In these studies, the patients may receive either the drug being studied or a control. Although the owners and veterinarians are aware that their pets and patients could receive either the experimental drug or the control — a placebo — they don’t know which treatment they actually get. In either case, owners have the option to drop out of a study at any time.
    When the goal is to treat a form of cancer that affects smaller numbers of animals, drug companies can use a pathway called conditional approval to bring drug treatments to market more quickly. Conditional approval allows a company to make its drug available to patients after proving the drug fully meets the FDA standard for safety and showing that there is a reasonable expectation that the drug is effective for the intended purpose.
    “Often small exploratory studies are conducted to support a reasonable expectation of effectiveness,” Troutman says.
    Conditional approvals have both pros and cons. On the plus side, they allow veterinary drug sponsors to provide patients quicker access to innovative treatments without waiting for the development of “substantial evidence” of effectiveness that would satisfy the requirement for a full approval.
    “On the other hand, because the studies used to support a reasonable expectation of effectiveness are small, the drugs may not turn out to be effective when they are used in greater numbers of animals,” Troutman says.
    The FDA may allow, through annual renewals, the conditionally-approved products to stay on the market for up to five years while the company collects the remaining effectiveness data required to support a new animal drug application for full approval. Conditional approval automatically expires at the end of five years and the drug is removed from the market if the company has not fully demonstrated that the drug is effective.
    FDA-Approved Drugs for Cancer in Dogs
    Troutman says that sponsors are continuing to develop innovative treatments for different types of cancer in dogs.
    “We’re looking at therapies that are more targeted now,” she says. Scientists are identifying proteins or other substances unique to cancer cells and developing treatments that target those substances without harming healthy cells.
    Currently, three drugs are approved, and another drug is conditionally approved to treat cancer in dogs:

    Palladia (toceranib phosphate), to treat mast cell tumors, was approved in 2009; 
    Stelfonta (tigilanol tiglate injection), to treat mast cell tumors, was approved in 2020;
    Tanovea-CA1 (rabacfosadine for injection), to treat lymphoma, conditionally approved in 2016 and fully approved in 2021; and
    Laverdia-CA1 (verdinexor tablets), to treat lymphoma, conditionally approved in 2021

    To date, there are no FDA-approved treatments for cancer in cats. Most cancer treatments for dogs and cats use drugs the FDA has approved for use in humans.
    What are the Warning Signs?
    The warning signs of cancer in dogs are similar to those in people, Troutman says: a lump or bump, a wound that doesn’t heal, any kind of swelling, abnormal bleeding. But generally, a pet owner should keep an eye out for what Troutman calls “the basics —changes in the normal functions of eating, drinking, peeing, pooping and sleeping — and contact their veterinarian if they have concerns.
    “Emotional state, such as being withdrawn and irritable, can be another sign,” she says.
    Both general veterinary practitioners and veterinary oncologists, as well as other specialists, treat cancer in cats and dogs. In general, veterinary practitioners work with veterinary oncologists to provide the diagnosis and the follow-up care for the pet during treatment, which may include blood work and imaging, such as x-rays or ultrasound examinations, to monitor the animal’s progress.
    There’s a fundamental difference between treating cancer in pets versus people. “Side effects from cancer treatment are usually fewer than those seen in people, and veterinarians work very hard to manage those side effects and maintain quality of life,” Troutman says. “There are even drugs that have been brought to market with the intent of managing common side effects, like vomiting or lack of appetite.”
    Questions to Ask Your Veterinarian
    Questions that pet owners may want to ask their veterinarian and veterinary oncologist when their pet has been diagnosed with cancer include:

    What treatments are available?
    What is the prognosis with each treatment?
    What are the side effects of each treatment and how will they affect my pet’s quality of life?
    How long will I need to treat my pet?
    Will this treatment cure my pet’s cancer? Will it make him more comfortable?
    What is the cost of each treatment?
    How many visits back to the veterinarian are needed?

    Pet owners who want to investigate clinical trials for their animal can go to the American Veterinary Medicine Association website.
    back to top

    MIL OSI USA News

  • MIL-OSI USA: Interview with Sean Colgan

    Source: NASA

    I’m really pleased that you agreed to take advantage of this opportunity.  I don’t recall if I have actually met you personally,  but if so, then I apologize for not remembering.

    I don’t think so, although you’ve certainly signed things for me.

    Well, I guess I have because I do remember seeing your name from time to time on various things. You’ve been at Ames a long time and we’ll have you talk about that in a little bit. The focus of these interviews is not specifically on your work. In fact, it was intended to broaden people’s understanding of who you are and what you do when you’re not at work, because we get compartmentalized and mostly get to know people through our work interactions, so we’ll be touching on your other interests. As you’ve seen if you’ve read some of these, we generally start with your childhood. I try to look up bios and things like that ahead of time to see what I can glean before these interviews but you don’t have a very substantial presence on the web.

    I’m not a very public person.

    I did find that out (laughs).

    I did not volunteer for these and I tried to lay low until you hunted me down! (laughs)

    Well, I think you’ll be pleased and as I said, you can stay as private as you want during this whole interview.

    Sounds good.

    We like to start with where you were born, your family at the time, what your parents did, if you have siblings, and then we ask when became aware of or developed an interest in what you have pursued as a career.

    OK, and I’m going to be looking sideways at my notes because I printed out your list of questions and thought about them. Hopefully I won’t mess it up too much. I’m a big believer in the written word. I was born in Oakland, just up the Bay.

    So was I, so we have a connection right there!

    Up through my preteen years I grew up split between Oakland and North Lake Tahoe. My dad was a masonry contractor. When school got out in June we would go up to Tahoe where there was lots of work for him, building foundations for homes and so forth. When Christmas break came in school, we came back down to Oakland. We had a home in both places and dad could get work in the winter in the Bay Area. In the middle of every year during my preteen years, I switched between two schools. It was usually a bit of a jolt because the Oakland schools were ahead of the Tahoe schools, so there were a couple weeks of flailing about in January trying to catch up. They all used the same textbooks, but we were a couple of chapters behind at that point and had to catch up.

    When I was 12, Dad had established his business well enough at Tahoe that my parents sold both of the houses, built a somewhat bigger one, and we moved to Tahoe permanently. So from seventh grade through high school it was all at the northern end of Lake Tahoe.

    I have one sibling, a brother.

    And when did I start thinking about becoming an astronomer? I can’t remember exactly, to be perfectly honest. I do remember my parents showing me the constellations. I can remember specifically which constellations my dad showed me and which ones my mom showed me. I can’t remember a time when I wasn’t interested primarily in being an astronomer, but I probably went through an astronaut phase because it was the ‘60’s!  I got an astronomy book for my birthday one year and I know it was before I could really read and understand it. I remember looking at the pictures. In thinking about this interview, I went back and looked.  That book was published when I was five, so probably by the time I was five I was talking about it enough that I got this book for my birthday. I don’t have any similar books on other topics from that time. All the other books I have from back then are astronomy books for kids.

    Well, you were living in Lake Tahoe, which by the elevation and the clarity and lack of ambient lights around you would have had a really good view of the stars and constellations.

    Right. It was great. Although before we moved up there full time we were mostly there in the summer, so it didn’t get dark until after my bedtime.  When we moved up there full time, then I could go out in the winter and yeah, we had a spectacular view of the southern sky. There were woods but we could see over the trees. We could see the center of the Milky Way, and so forth. I had binoculars and a couple of small telescopes that I’d use, along with a star atlas to point me toward interesting things to look at.

    Did you say what your mother did? Did she work outside the home?

    Mom was a writer.  We traveled each year when we were growing up. She would write travelogues of those trips and try to get them published. She also wrote haiku poetry, and she tried her hand at writing other things. She was published a bit, but not a whole lot. Mom did get one of her travelogues published in the Christian Science Monitor. That was a highlight for her.

    And was your brother older or younger?

    My brother is two years younger, and we had somewhat similar trajectories.  We’ll get to education later but he majored in physics as well. He followed me in similar universities, but ended up going into material sciences. He is now on the East Coast working for IBM.

    That’s great.

    He was named a Master Inventor in 2018.

    A what?

    A Master Inventor. He has over 200 patents, so IBM honored him with this title.

    That’s quite an honor!  Your education was interesting because of the split between the two schools.  But then at some point, when you went to college, you had to declare a major. You said you had already developed an interest in astronomy, so did you pursue that science discipline right off the bat?

    I went to UC Riverside for two years, and then I transferred to Caltech. My freshman year  I really nailed down my choice for astronomy. I remember going to the Career Center and taking an interest survey, which has nothing to do with what you’re able to do. It just asks what you’re interested in doing, and it came up as physicist or musician.  I have no musical skills so that pointed me in the other direction. I thought briefly about geology, since my dad had been a geology major, but I really settled on astronomy at that point, which is why I transferred. Riverside didn’t have an astronomy major,  they only had a physics major. I really wanted to get an astronomy background and start on it early.

    My time at Caltech was probably the toughest two years I’ve ever had. I was behind because I had gone to Riverside for two years and the Caltech student body was extremely competitive. Caltech was not generous with their transfer credits. I ended up taking a very heavy course load, but I did make it out in two years. From there I applied to a number of grad schools. I settled on Cornell for a couple reasons: First of all because they had groups working in the areas  of astronomy I thought I was interested in, which were radio and infrared. Second of all, after four years in southern California I really wanted to go to a more rural setting to continue my education.

    I have to ask this because when we’ve interviewed others who have gone to Cornell, most of them have mentioned the influence of Carl Sagan and I just wondered if that figured into your choice, or was he gone by the time you went there?

    Well, I  did meet Carl, at a second year reception he threw for the grad students.  He was gone most of my first year working on Cosmos the television show. He had taken a leave of absence and wasn’t around. When he came back he threw a reception for all of us, and I got to shake his hand. He was a planetary scientist, of course, and that was not where I was aiming my trajectory.  I didn’t see him a whole lot other than that one reception. Although from time to time the kind of people you really don’t want wandering around the halls would come around the building looking for Carl Sagan. Security would chase them down and get them out. These are really my most distinct memories of Carl.

    And your PhD was in astronomy, not physics?

    It was in astronomy and my dissertation was on radio astronomy. I did it almost exclusively at Arecibo (Arecibo Observatory, National Astronomy and Ionosphere Center, Arecibo, Puerto Rico) with a little bit at the VLA (Very Large Array Radio Telescope facility, near Socorro, New Mexico). I got to work with some really smart people at Cornell, observational and theoretical.

    At this point we usually inquire about the connection or the influence, that brought you from your PhD to NASA Ames.

    My degree was in radio astronomy but the other interest I always had along the way, which I hadn’t been able to look into, was infrared astronomy. Getting post docs is very competitive, back then we called them NRC’s. The NRC offer from Ed Erickson’s group at Ames was the best offer, so I came out for that. It wasn’t a sure thing, there was back and forth and the highest rated candidate had to turn down the job before they would make me an offer.  But fortunately for me the highest rated candidate was my office mate at Cornell. I knew he was going to turn down the offer as soon as he got another one he wanted, so I was aware a little bit in advance of getting the call from Ed that things had worked out.

    And Ed was your advisor?

    Ed was my advisor. So I came and did two years as an NRC and then continued working with the group. I had made myself sufficiently useful that when I was ready to apply for other jobs, Ed offered me a raise if I’d stay with the group and continue working. That was a really good time. We flew on the KAO (Kuiper Airborne Observatory). They didn’t really have facility instruments, so we had our own instrument, but we did support observers from outside our group. We probably had more flights than any other instrument on the KAO during that period. It was a lot of flights. We had to operate it ourselves. All of us had our own particular jobs on flights. We did everything from prepping for the observations, writing proposals, all the way through to seeing them published. We were a small team: Ed Erickson, Mike Haas; Jan Simpson, and Bob Rubin on the science side helped out. We had a shop guy, Gene Beckstrom, and others after him.  We had a lab technician, Jim Baltz. Dave Hollenbach would also work with us, and that was very rewarding. He was a very sharp guy in terms of theory, ideas and projects to do. Here is a photo of some of us with our instrument rack getting ready for a KAO flight:

    So you came in on an NRC postdoctoral fellowship in the mid-‘80’s?

    Yes, I started on October 6th, 1986.

    And your first work was on the KAO and then probably a decade later you continued on SOFIA (Stratospheric Observatory for Infrared Astronomy)?

    It was ‘95 or ‘96 when they shut down the KAO to use the funding for SOFIA development. I remember the meeting still. It was in the upstairs auditorium and they came in and announced they were shutting the KAO down. I think it was Dave Morrison, who was the division chief, who told us not to whine about shutting it down because planetary missions sometimes had years when they didn’t have their facilities. In this case it was only going to be two years and we would be up and flying in 1997. Of course, as we know, it was more like ten years after that before we were even close to flying.

    Yes, I thought the same thing, that it was not going to be two years. It always takes longer than that.

    Well, I don’t think anybody thought it was going to be as many years as it was.

    But you flew on both the KAO and SOFIA?

    I had ninety nine flights on the Kuiper (KAO) because I kept track of them, and on SOFIA I had two flights, so I was not a flyer on SOFIA. It was more of a facility observatory, and the people who flew a lot were really part of the observatory. They were operating the telescope or operating a science instrument. My flights on SOFIA were because I had written some software for the GREAT Instrument (German Receiver for Astronomy at Terahertz Frequencies, a modular dual-color heterodyne instrument for high-resolution far-infrared spectroscopy) to help them interface with SOFIA. I was along on  those commissioning flights for GREAT in case my software broke. They wanted me on board. Interestingly by the rules at the time, I wouldn’t be allowed to actually fix the software in flight because it was flight software and had to go through all the reviews. None of the people who could do the reviews were on the airplane, but I could see how it broke and maybe I could suggest workarounds. It was not nearly as much fun for me as the KAO. I didn’t really have a job. The software had issues from time to time, but it basically worked. Everybody else had jobs, so for me it was less interesting, which is why I didn’t make a huge effort to keep flying on SOFIA.

    Did you stay on the SOFIA project as a somewhat non flying support person?

    Yes, from when the Kuiper stopped flying until about, well now, my primary work on SOFIA has been first with the project science team during development – trying to make sure they met our requirements, helping everybody understand our requirements, trying to make sure they weren’t making any huge mistakes. They made them anyway, especially when they didn’t listen to us, but we did our best. During the early years of SOFIA, I was also on the Ames team developing AIRES – a facility Science Instrument for SOFIA. I led the software effort, but the development was canceled in 2001. I then got involved with the software that people would use to propose to SOFIA, the proposal software, the software to estimate how long you should be asking for time, the sensitivity of the instruments, pieces of software like that. I worked with Dave Goorvich. We got software from other observatories as starting points and then modified them for SOFIA, software “re-use” they called it. And that was basically my main job throughout SOFIA’s lifetime. Once we developed those, the USRA (Universities Space Research Association) folks built their team around maintaining them and I joined that team because I’d been working on this software for so long. I also got into the package I mentioned to help GREAT interface to SOFIA. It basically made SOFIA look like the telescope that the GREAT team had been using for years, an observatory called KOSMA. We called it the translator and it translated KOSMA commands into SOFIA commands; then SOFIA housekeeping back into KOSMA housekeeping, so they didn’t need to change their software to work with SOFIA. As the aircraft started flying, it became quite clear that I was oversubscribed. I was not meeting my deadlines for either of those two efforts, so I gave up the translator. They hired another fellow to maintain that, although I stayed in touch with it for some years, helping him when he had questions and so forth. I then focused my main effort over on SOFIA’s DCS (Data Cycle System) side.              

    What has been your most interesting work here at Ames?

    I’d say it was flying on the KAO, but very specifically it was Supernova 1987A which occurred after I had been here for only a couple of months. It went off in February of 1987. Nobody really knew what it would look like in the infrared to an instrument on an observatory like the KAO, so it was obviously a huge deal since it was the closest supernova for hundreds of years.  Our team just completely redirected  to carry out observations of the supernova.  Dave Hollenbach and I worked together to try and figure out what we would see. We wrote up the science portion of the proposal,. For these observations, our instrument – the CGS (Cooled-Grating-Spectrometer) – had to be fairly substantially reworked in the sense that the grating needed to be changed to go to lower resolution and the detectors needed to be changed to get wider bandwidth and go to shorter wavelengths. Ed and Mike worked long days, weeks, and months to make all of those changes happen. In our proposal we made some predictions about which lines we could see, mostly iron lines, and which ionization states. We put that in the proposal, which was accepted. We then wrote up the proposal as a separate paper. When we went down and did the observations, we actually got some of it right. Surprisingly, iron was indeed bright. We thought we’d be seeing all different ionized states of iron, from singly, doubly, triply ionized iron, when in fact it was very much concentrated in singly ionized iron with a little bit of doubly ionized iron, there was a faint line there. We had gotten the temperatures right, but we didn’t quite get the ionization right. We were in the ballpark, so I think this was really the most interesting work in that when we started nobody had really seen anything like it before. We were starting from very basic principles, and we followed that all the way through to a nice series of papers. We went down for three different epochs because the lines were changing with time as the supernova ejecta expanded. We obtained three sets of measurements, which resulted in three papers.

    What I’m currently working on? Well, SOFIA is, of course, shut down and I am working as part of the shutdown process. We’re trying to reprocess a lot of the data to bring it up to standard, especially the older data. We learned more about the instruments as time went on, so we can now do a better job of reducing the data. I’m helping out with reducing the data, getting it into the archive as we shut down, and of course, writing proposals.

    What comes next? So far I’ve collaborated mainly with Naseem, whom you have spoken to, Sarah Nickerson, whom you also have spoken to, and Doug Hoffman (whom we’ve also spoken to). So that’s proposals.

    How is your work relevant to Ames and the NASA mission? 

    Well, I’ve worked on NASA missions almost my entire career, so I think that’s the closest to relevance as you can get.

    What is a typical day like for you?

    I mostly work, well before the pandemic in my office, but now it’s back and forth. I do like to come into the office although this week is a little different. That’s why we’re doing this interview from home. My wife is out of town and I like to work at home on those weeks just to keep the dog out of trouble. So I’m at a computer. I’m a software guy and a data analysis guy, not a lab guy, so I work at the computer. I actually have several computers on my desk. I look like a real developer (laughs). If you see my desk, I’ve got a couple of big screens and couple of computers underneath hooked up to different things and I can switch them around. So that’s a typical day, but at home it’s a little tougher. I don’t have a desk that can really manage the big screens, so I’ve just got one little laptop screen to work with.

    Is home close enough that the pandemic shut down of the Center didn’t really save you a whole lot of commute time?

    I live across the Bay in Newark, which physically is not far, but traffic wise is not good. I typically come in later and stay later because that works with my wife’s schedule and also works with the traffic. We’re not so close that it’s easy. I hated during the pandemic having to work at home all the time because of the small screen and with no room to spread out piles of paper or stay organized. That was definitely a challenge. I was very glad to get back on site.

    What do you like most and least about your job?

    Most would be doing science, but I also enjoy coding. Least is probably the standard sorts of things that most people whine about when given any opportunity.  All the stuff that goes with the job that isn’t science or coding, like IT security and paperwork. Right now I’m in the midst of training, taking courses I’ve taken every year for the last ten years, which gets a little old after a while, things like that. But somebody thinks you need to do it, and I hope it makes us a better organization for everybody doing it.

    Do you have a favorite memory from your career? Or perhaps a research finding or breakthrough, or an unexpected research result?

    My favorite memory would be the Supernova 1987A work in general. We found some unexpected things there and we got some things right.

    If you could have a dream job, what would it be?

    My dream job is pretty close to what I have. Pretty close without all the extra stuff.

    What advice would you give to someone who wants a career like yours?

    Of course you’ve got to work hard, and you need to have an aptitude for it. It’s a very competitive field, so you’ve also got to realize that luck, or being in the right place at the right time, can be a factor in whether you continue or not.  I’ve had colleagues who were very good at what they do, but they just weren’t in the right place at the right time. They ended up leaving the field or doing something less than what they hoped. Some things are just out of your control.

    I did get lucky. I was in the right place at the right time. I flew on the Kuiper, and I developed skills. When SOFIA started, those skills were very much in demand.  That was my right place, right time moment, which is when I joined the civil service.  I had been a contractor  after my NRC ended through 1997. I became a civil servant then because there was so much work on SOFIA. I don’t know if that’s  helpful advice, but it’s just my take on things.

    Well, you’re right. There’s something to being in the right place, at the right time and being prepared, but there’s always the serendipity aspect, which is just part of life. You could have wound up somewhere else and been just as happy, you know.

    Oh yes, It doesn’t necessarily relate to happiness, but you’ve got to make the best with what you have.  I do feel lucky about that.

    Would you like to share anything about your family? Kids, pets, activities? You mentioned a dog?

    I’m going to mix the order up a little bit.

    Sure, go ahead.

    The accomplishment I’m most proud of that’s not science related would be 40 years of marriage to my fabulous wife. We just celebrated our 40th anniversary about a week and a half ago.

    Congratulations! That is indeed an accomplishment.

    So, no children but we do have a dog, a little Welsh Corgi. She’s our second corgi and she is just great. We do enjoy traveling. Typically, we’ll go on vacation in August. often to Europe. We’ve visited the UK five or six times, France a couple of times, Italy a couple of times. My father-in-law was born in Hungary, so we’ve gone there a couple times. Here is a photo of us at Lake Louise in 2019, with our Corgi.

    What do we do for fun the rest of the time? Besides leisure travel, I enjoy gardening. We also enjoy musical events.  We have season tickets to the San Jose Opera, for example, and we’ll go up to San Francisco for concerts a couple of times a year. We probably have an event every other month.  During the pandemic, the restaurants and movie theaters were closed, but wineries with outdoor spaces were open.  They started serving food during the pandemic, and they allowed dogs, so we got in the habit of doing a lot of wine tasting on weekends just to get out. We still do some of that. To celebrate our 40th, we went up to Napa and tasted a lot of great wines. (laughs)

    You mentioned that you’re not particularly musical, so you don’t play an instrument or anything, but you enjoy music and opera.

    I enjoy listening to music. I played instruments as a child but had no particular talent for it, so. . . .

    Do you like to read? And if so, any particular genre?

    I read a fair bit, and it’s sort of divided. For entertainment, I’ll read fantasy and science fiction, but when we go on our trips, I’m always buying books about what we’re doing. For example, if we go to France and visit cathedrals, I’ll buy books about how they built cathedrals; or in England I’ll read about old Stone Age tombs. Everybody’s heard about Stonehenge, but there are stone circles and other stacks of stones, big ones, all over the landscape, so I will buy books and read about them. I have books about Roman battle tactics, etc. Oh yes, and I also have a lot of geology books, depending on where we go. When we went to the Canadian Rockies, I got a lot of geology books about that locale. I bring those home, stack them up, and read them, hopefully before the next trip. So yes, a lot of reading. When my wife travels, sometimes I’ll go hiking. She’s gone up to 15-20 weekends a year  She’s a textile artist.She teaches lacemaking, which is the way they used to make lace by hand, before machines. There are groups around the country that enjoy lacemaking, so she travels to  teach workshops for them on weekends.

    Wow, that’s fascinating!

    This week, she’s actually up in Sparks, next to Reno, where the National Convention is going on. It moves around every year, but this year it’s relatively close. She travels a lot for that, which keeps her busy. When she’s away, our dog and I will sometimes go for hikes, if we don’t have too much other stuff to do. Interestingly,  we are not the only astronomer-lacemaker couple in the world (laughs). There’s an Australian couple – Ron and Jay Ekers – with Jay a lacemaker and Ron an astronomer. We had dinner with them once when they were visiting in the Bay Area because our wives knew each other. My wife had once traveled down to teach in Australia. Normally she just travels around the U.S., but she has done some international trips.

    Now, is this manual lacemaking with needles and thread or . . . ?

    There can be needles and thread. That’s one form of it. What my wife teaches is “bobbin lace”, which is made on a pillow usually stuffed with straw. Two bobbins are connected by a thread with many of these pairs used to weave threads together to create the pattern. Photos of Louise’s designs are on her website – https://colganlacestudio.com/. Here’s a photo of what a lace pillow looks like.

    Interesting. And when did she get interested in this? Was it something she learned as a child, from her mother or grandmother?

    No, it was at Cornell. She was in grad school there, which is where we met.

    And what was her course of study?

    She was in a Master’s program for historic preservation, basically how to preserve old buildings, of which there are many in upstate New York and few in the Bay Area. She had finished her class work, and I still had several years to go on my dissertation. She looked around for something to fill her time, and one of her friends – a colleague in her department – had already taken this up, and brought her to a meeting. She started taking classes from a local teacher, and by the time we moved west, she was well-versed. Not many people out here knew how to do it, so she started taking on students.

    So I’m calculating back, since I’m a numbers guy, that if you just celebrated your 40th anniversary, then you must have married her while you were still in grad school?

    Yes, about halfway through grad school, in 1983.

    Interesting. So you’re a little bit responsible for her developing this interest in lacemaking?

    I wouldn’t claim any of that.

    But you’re responsible for giving her the time to develop this interest in lacemaking that she has done so well in.

    It was all her effort. If anything, I made conditions difficult for her, and she found her way out (laughs). That’s probably the way I would phrase it.

    Fair enough. But it’s very interesting. I like when we can poke around a little bit and find out interesting things, because then people who read this will say, “Well, I didn’t know that he went there or that his wife does lacemaking or the other things that you’ve talked about. That’s part of the purpose of these interviews.  Who or what inspires you?

    That was a real easy one for me: the night sky.  It’s not so great in the Bay Area most times, but there’s so much going on up there. I mean, it’s really all laid out for you. Since I studied and read about  a lot about the sky as a kid, I know my way around it. a I also know fun little facts, so that’s entertaining to recall as well. When you get up in the mountains, of course it’s just beautiful.

    I feel the same way. I don’t see how anyone can look up at and ponder the night sky and not be just fascinated by it. The questions that come up about what it is, how it came to be, what its purpose is, if there is one, and all of that is just fascinating.

    Yes, I agree.

    Do you have a favorite image, of space or anything that is particularly meaningful to you?

    You know I don’t have one now. I mean, there are a lot of very nice ones out there. A big favorite I remember as a kid was a photo of H and Chi Persei, which is a double cluster of stars, not globular clusters but open clusters. It’s very colorful, with red stars and white stars and blue stars in the image – and just imagining it so far away, but these particular stars are so close together. I don’t know much about it, but something about it just impressed me. A photo like what I remember is at https://www.astrobin.com/337742/.

    The reason we ask about images is because we like to include them in the post, especially about things you’ve talked about.  You mentioned for example, the Supernova 1987A. If a picture from SOFIA came out of that it would be a great addition to this interview. And then maybe you have a picture of you and the corgi on a hike, or your wife doing lace work, anything like that would be great.

    Well, we’ll work on that.

    [Photo thoughts: The three of us from Lake Louise, link to H & Chi Persei photo on the web, Lace Pillow showing bobbins]

    That would be for when you return it after editing.  By the way the transcript is a living document so you can make changes right on it and that’s how it will go in. It isn’t all that formal, we’re not tracking edits or anything like that. We’ll add your pictures and get to a point where it’s set up as it would be when it gets posted and then we’ll send it to you for a final check.  We’re also several months out in terms of the queue of those that are going to be posted, so it won’t be immediate.

    Good.

    We’ve posted about 50 of these, but we’ve done another 20 that are in various stages of being made ready. We’ve sent them out but haven’t gotten them back yet because everybody’s so busy.  We do have a last question and that is do you have a favorite quote? One that you find meaningful, or witty, or clever, that kind of thing?

    I did think about it. Sometimes you asked the question in the online ones about inspirational quotes and this is definitely not inspirational.

    It doesn’t have to be.

    I was hoping that because you didn’t say it here. My favorite quote is one my mom said a lot when I was growing up. She always attributed it to her father. I actually looked it up on the web, because I would have thought Mark Twain perhaps said it. It doesn’t seem that anybody famous has said it though. The reference is in a book from just ten years ago. The quote is: “The reward for good work is more work.”

    Ah, I like that. That’s clever and witty and seems to be true.

    Right.

    One of my favorite quotes which I don’t think I put into my post because there’s so many of them is from Mike Griffin, former NASA Administrator. He was talking with the press, I think about risk management and why we do things that don’t always work out. He was explaining that there’s always a risk, and if you don’t accept the risk, then you don’t make progress, but they kept questioning him and pushing back on that idea. And he said, “I can explain it to you, but I can’t understand it for you.”  And I thought, that’s a good line!

    Anyway, you ran the table here on the questions and I appreciate that you prepared ahead of time and wrote some notes down, which made the interview go very well.

    As I said, I prefer the written word. I’m not as good at thinking on my feet.

    Is there something that you wish we had asked or had put down as a topic that we didn’t, that you would like to add here? And you can certainly add or change anything when we send this back. There’s a note on the transcript that you have full creative control. So if you wanted to say something but didn’t, you can type in an entire extra paragraph or extra question, or remove and cut out an entire section.

    And  with that, I’ll take the recording and start putting it on a paper and within a couple of weeks, I’ll send you the initial draft and then you can do with it as you wish and send any pictures or anything that relate to things that you talked about and then we’ll get it ready and put it in the queue and eventually you’ll get perhaps a few of your entitled 15 minutes of fame when this goes up. I will add that it goes up on the public side of the of the website so that your family or your friends, anybody can access it and read it.

    So if somebody googles names of interviews you’ve done, the links to the interviews come up.

    Well, I hope that doesn’t cause you heartburn.

    I’ve thought about that as I was phrasing my answers, and changed some passwords so I can include names in the photo captions

    I hadn’t thought of that aspect of it, but you’re probably right.

    Yeah.

    I never know what’s going to touch someone’s concerns.

    Well, just to be careful.

    (Mark) There’s another thing that even after we publish, we can still edit them years into the future. Everything on the main sites can be changed at any given moment. Also, Fred, just to note, our interviews rank pretty high on the Google rankings. Usually when you Google someone’s name and then NASA, our interviews are near the top of their results, like on the first screen that comes up.

    (Fred) Oh, really? I didn’t know that.

    (Mark) Yeah. This is a pretty good series, people check it out a lot.

    Which means that people googling names are clicking on the interviews and reading them.
    (Mark) People read these a lot.

    (Fred) The other series I do for the website is “Interesting Fact of the Month”.  Steve Howell suggested that would be a nice addition as we try to attract traffic to the website, and I heard a year or so ago that it was the top item on the code ST website, it got the most hits.

    (Mark) Yes, you’ve got spots one and two on your side projects!

    (Fred) Well, Sean, I appreciate that you were able to overcome your initial hesitation and take the time to work with us on this and I think you’ll be pleased with how it comes out. Thank you very much for being so organized.

    Thank you for your time.

    Interview conducted by Fred Van Wert and Mark Vorobets on June 29, 2023

    MIL OSI USA News

  • MIL-OSI USA: Fire Grows Unusually Large in Japan

    Source: NASA

    The largest wildland fire to burn in Japan in decades spread amid dry, windy conditions in late winter 2025. As of March 3, it had consumed an estimated 2,100 hectares (8.1 square miles) of forested land near Ofunato, a small port city approximately 400 kilometers (250 miles) north of Tokyo.
    Japan’s Fire and Disaster Management Agency (FDMA) said the fire ignited by 1 p.m. local time on February 26. Three days later, on March 1, the MODIS (Moderate Resolution Imaging Spectroradiometer) on NASA’s Terra satellite captured this image of smoke billowing from the blaze. A thick plume lingers near the coast and appears to cast a shadow over the Ofunato area, while some smoke drifts east over the Pacific Ocean.
    By March 1, the day this image was acquired, the fire had burned through an estimated 1,200 hectares (4.6 square miles) of forest, making it the country’s largest blaze in over 30 years. A 1992 fire on the northern island of Hokkaido burned 1,030 hectares, a fire agency spokesperson told The Japan Times.
    Wildfires frequently occur in Japan between January and May, when the air is drier, but they tend to be much smaller in size than the one burning in early 2025, according to news reports. However, conditions were unusually dry leading up to this event. Ofunato received only 2.5 millimeters (0.1 inches) of precipitation in February 2025, the lowest monthly total for February in a record going back to 1964. Strong winds that fanned the flames and steep terrain that challenged containment efforts also contributed to this fire’s growth, experts told news outlets.
    In addition to burning through forested land, the fire damaged dozens of structures and prompted officials to issue evacuation orders to more than 4,500 people, said FDMA. According to news reports, more than 2,000 firefighters from across the country were deployed to combat the blaze.
    NASA Earth Observatory image by Lauren Dauphin, using Landsat data from the U.S. Geological Survey. Story by Lindsey Doermann.

    MIL OSI USA News

  • MIL-OSI USA: Outsmarting Poison Ivy and Other Poisonous Plants

    Source: US Food and Drug Administration

    [embedded content]

      Espanol
    First comes the itching, then a red rash, and then blisters. These symptoms of poison ivy, poison oak, and poison sumac can emerge any time from a few hours to several days after exposure to the plant oil found in the sap of these poisonous plants. The culprit: the urushiol oil. Here are some tips to avoid it.
    Recognizing Poison Ivy, Poison Oak, and Poison Sumac

    Poison Ivy: Found throughout the United States except Alaska, Hawaii, and parts of the West Coast. Can grow as a vine or small shrub trailing along the ground or climbing on low plants, trees and poles. Each leaf has three glossy leaflets, with smooth or toothed edges. Leaves are reddish in spring, green in summer, and yellow, orange, or red in fall. May have greenish-white flowers and whitish-yellow berries.
    Poison Oak: Grows as a low shrub in the Eastern and Southern United States, and in tall clumps or long vines on the Pacific Coast. Fuzzy green leaves in clusters of three are lobed or deeply toothed with rounded tips. May have yellow-white berries.
    Poison Sumac: Grows as a tall shrub or small tree in bogs or swamps in the Northeast, Midwest, and parts of the Southeast. Each leaf has clusters of seven to 13 smooth-edged leaflets. Leaves are orange in spring, green in summer, and yellow, orange, or red in fall. May have yellow-greenish flowers and whitish-green fruits hang in loose clusters.

    Poison Plant Rashes Aren’t Contagious
    Poison ivy and other poison plant rashes can’t be spread from person to person. But it is possible to pick up the rash from plant oil that may have stuck to clothing, pets, garden tools, and other items that have come in contact with these plants. The plant oil lingers (sometimes for years) on virtually any surface until it’s washed off with water or rubbing alcohol.
    The rash will occur only where the plant oil has touched the skin, so a person with poison ivy can’t spread it on the body by scratching. It may seem like the rash is spreading if it appears over time instead of all at once. But this is either because the plant oil is absorbed at different rates on different parts of the body or because of repeated exposure to contaminated objects or plant oil trapped under the fingernails. Even if blisters break, the fluid in the blisters is not plant oil and cannot further spread the rash.
    Tips for Prevention

    Learn what poison ivy, oak, and sumac plants look like so you can avoid them.
    Wash your garden tools and gloves regularly. If you think you may be working around poison ivy, wear long sleeves, long pants tucked into boots, and impermeable gloves.
    Wash your pet if it may have brushed up against poison ivy, oak, or sumac. Use pet shampoo and water while wearing rubber gloves, such as dishwashing gloves. Most pets are not sensitive to poison ivy, but the oil can stick to their fur and cause a reaction in someone who pets them.
    Wash your skin in soap and cool water as soon as possible if you come in contact with a poisonous plant. The sooner you cleanse the skin, the greater the chance that you can remove the plant oil or help prevent further spread.

    Tips for Treatment
    Don’t scratch the blisters. Bacteria from under your fingernails can get into them and cause an infection. The rash, blisters, and itch normally disappear in several weeks without any treatment.
    You can relieve the itch by:

    Using wet compresses or soaking in cool water.
    Applying over-the-counter topical corticosteroid preparations or taking prescription oral corticosteroids.
    Applying topical OTC skin protectants, such as zinc acetate, zinc carbonate, zinc oxide, and calamine dry the oozing and weeping of poison ivy, poison oak, and poison sumac. Protectants such as baking soda or colloidal oatmeal relieve minor irritation and itching. Aluminum acetate is an astringent that relieves rash.

    See a doctor if:

    You have a temperature over 100 degrees Fahrenheit.
    There is pus, soft yellow scabs, or tenderness on the rash.
    The itching gets worse or keeps you awake at night.
    The rash spreads to your eyes, mouth, genital area, or covers more than one-fourth of your skin area.
    The rash is not improving within a few weeks.
    The rash is widespread and severe.
    You have difficulty breathing.

    Content current as of:
    06/09/2021

    Regulated Product(s)

    Health Topic(s)

    MIL OSI USA News

  • MIL-OSI USA: FDA 101: Dietary Supplements

    Source: US Food and Drug Administration

    Image

    Español
    Multivitamins, vitamin D, echinacea, and fish oil are among the many dietary supplements lining store shelves or available online. Perhaps you already take a supplement or are thinking about using one. Dietary supplements can be beneficial to your health, but they can also involve health risks. So, it’s important that you talk with a health care professional to help you decide if a supplement is right for you.
    Read on to learn what dietary supplements are, are not, what role the U.S. Food and Drug Administration has in regulating them, and how to make sure you and your family use supplements safely.
    What Are Dietary Supplements?
    Dietary supplements are intended to add to or supplement the diet and are different from conventional food. Generally, to the extent a product is intended to treat, diagnose, cure, or prevent diseases, it is a drug, even if it is labeled as a dietary supplement. Supplements are ingested and come in many forms, including tablets, capsules, soft gels, gel caps, powders, bars, gummies, and liquids.
    Common supplements include:

    Vitamins: such as multivitamins or individual vitamins like vitamin D and biotin
    Minerals: such as calcium, magnesium, and iron
    Botanicals or herbs: such as echinacea and ginger
    Botanical compounds: such as caffeine and curcumin
    Amino acids: such as tryptophan and glutamine
    Live microbials: commonly referred to as “probiotics”

    What Are the Benefits of Dietary Supplements?
    Dietary supplements can help you improve or maintain your overall health, and supplements can also help you meet your daily requirements of essential nutrients.
    For example, calcium and vitamin D can help build strong bones, and fiber can help to maintain bowel regularity. While the benefits of some supplements are well established, other supplements need more study. Also, keep in mind that supplements should not take the place of the variety of foods that are important for a healthy diet.
    What Are the Risks of Dietary Supplements?
    Before buying or taking a dietary supplement, talk with a health care professional—such as your doctor, nurse, registered dietician, or pharmacist—about the benefits and risks.
    Many supplements contain ingredients that can have strong effects in the body. Additionally, some supplements can interact with medications, interfere with lab tests, or have dangerous effects during surgery. Your health care professional can help you decide what supplement, if any, is right for you.
    When taking dietary supplements, be alert to the possibility of a bad reaction or side effect, also known as an adverse event.
    Problems can occur especially if you:

    If you experience an adverse event while taking a dietary supplement, immediately stop using the supplement, seek medical care or advice, and report the adverse event to the FDA.
    How Are Dietary Supplements Regulated?
    The Law
    The Federal Food, Drug, and Cosmetic Act was amended in 1994 by the Dietary Supplement Health and Education Act, often referred to as DSHEA, which defined “dietary supplement” and set out the FDA’s authority regarding such products. Under existing law:

    The FDA does NOT have the authority to approve dietary supplements for safety and effectiveness, or to approve their labeling, before the supplements are sold to the public.
    Under the FD&C Act, it is the responsibility of dietary supplement companies to ensure their products meet the safety standards for dietary supplements and are not otherwise in violation of the law.
    Dietary supplement labels are required to have nutrition information in the form of a Supplement Facts label that includes the serving size, the number of servings per container, a listing of all dietary ingredients in the product, and the amount per serving of those ingredients. They also must have a statement on the front of the product identifying it as a “dietary supplement” or similar descriptive term, e.g., “herbal supplement” or “calcium supplement”. 

    In general, even if a product is labeled as a dietary supplement, a product intended to treat, prevent, cure, or alleviate the symptoms of a disease is a drug, and subject to all requirements that apply to drugs.
    The FDA’s Role and Actions to Help Keep You Safe
    Even though the FDA does not approve dietary supplements, there are roles for the agency in regulating them.

    Since companies can often introduce a dietary supplement to the market without notifying the FDA, the agency’s role in regulating supplements primarily begins after the product enters the marketplace.
    The FDA periodically inspects dietary supplement manufacturing facilities to verify companies are meeting applicable manufacturing and labeling requirements.
    The FDA also reviews product labels and other labeling information, including websites, to ensure products are appropriately labeled and that they do not include claims that may render the products drugs, e.g., claims to treat, diagnose, cure, or prevent diseases.
    The FDA monitors adverse event reports submitted by dietary supplement companies, health care professionals, and consumers as well as other product complaints for valuable information about the safety of products once they are on the market.
    If a product is found to be unsafe or doesn’t otherwise comply with the law, the FDA can:

    Work with the company to bring the product into compliance.
    Ask the company to voluntarily recall the product.
    Take action to remove a dangerous product from the market.

    Tips to Be a Safe and Informed Consumer
    Before taking a dietary supplement, talk with your health care professional. They can help you decide which supplements, if any, are right for you. You can also contact the manufacturer for information about the product.

    Take only as described on the label. Some ingredients and products can be harmful when consumed in high amounts, when taken for a long time, or when used in combination with certain drugs or foods.
    Do not substitute a dietary supplement for a prescription medicine or for the variety of foods important to a healthy diet.
    Do not assume that the term “natural” to describe a product ensures that it is safe.
    Be wary of hype. Sound health advice is generally based upon research over time, not a single study.
    Learn to spot false claims. If something sounds too good to be true, it probably is.

    Why Is It Important to Report an Adverse Event?
    If you experience adverse event, also known as a side effect or bad reaction, the FDA encourages both you and your health care professional to report the adverse event to the FDA.
    You can help the FDA, yourself, and other consumers by reporting an adverse event. A single adverse event report can help us identify a potentially dangerous product and possibly remove it from the market.
    For a list of potential serious reactions to watch for, and to learn how to report an adverse event, please see the FDA’s webpage, How to Report a Problem with Dietary Supplements.
    Adverse events can also be reported to the product’s manufacturer or distributor through the address or phone number listed on the product’s label. Dietary supplement firms are required to report serious adverse events they receive about their dietary supplements to the FDA within 15 days.
    As a part of FDA modernization efforts for field operations, all of our Centers now directly receive reports of problems or adverse reactions with FDA-regulated products. Please direct concerns to the appropriate FDA center by visiting our SmartHub webpage, which will guide you to the appropriate webform or phone number.
    If you are not able to use the SmartHub, you may also call 1-888-INFO-FDA and follow the prompts to report a problem. If you require the use of a Relay Service, please call the Federal Relay Services at 800-877-8339. This is a toll-free relay service to call federal agencies from TTY devices.
    NOTE: The ORA consumer complaint coordinator telephone numbers previously available are no longer in use.
    Additional Resources:

    MIL OSI USA News

  • MIL-OSI USA: Mixing Medications and Dietary Supplements Can Endanger Your Health

    Source: US Food and Drug Administration

    Image

    Español
    When you take prescription or over-the-counter medications, do you also take a vitamin, mineral, or other dietary supplement? Have you considered whether there is any danger in mixing medications and dietary supplements?
    There could be. Certain dietary supplements can change absorption, metabolism, or excretion of a medication. If that happens, it can affect the potency of your medication, which means you may get either too much or too little of the medication you need.
    Dangers of Mixing Medications and Dietary Supplements
    Dietary supplements are widely used and include vitamins, minerals, and other less familiar substances—such as amino acids, botanicals, and botanical-derived ingredients. Tens of millions of people in the U.S. take some kind of dietary supplement along with a prescription medication.
    Combining dietary supplements and medications could have dangerous and even life-threatening effects. For example, drugs for HIV/AIDS, heart disease, depression, treatments for organ transplants, and birth control pills are less effective when taken with St. John’s wort, an herbal supplement. Depending on the medication involved, the results can be serious.
    In addition, warfarin (a prescription blood thinner), ginkgo biloba (an herbal supplement), aspirin, and vitamin E (a supplement) can each thin the blood. Taking any of these products together may increase the potential for internal bleeding or stroke.
    Don’t Assume “Natural” Means Safe
    Some consumers may believe that a so-called “natural” product, such as an herbal supplement or fish oil, can’t hurt them. Natural does not always mean safe.
    For example, many weight loss products claim to be “all-natural” or “herbal,” but their ingredients may interact with medications or may be dangerous for people with certain medical conditions.
    Precautions for Children and for Those Who Are Pregnant or Breastfeeding
    Children, in particular, could be harmed by taking both supplements and medicines. Children’s metabolisms are unique, and at different ages they metabolize substances at different rates. For kids, ingesting dietary supplements together with other medications make adverse events a real possibility. And if you’re pregnant or breastfeeding, you’ll want to discuss any dietary supplements with their health care professional.
    Considerations Before Surgery
    If you’re planning a surgery, be aware that some dietary supplements can interact in a harmful way with medications you need to take before, after, or during that surgery. Your health care professional may ask you to stop taking dietary supplements two or three weeks before the procedure to avoid potentially dangerous changes in heart rate, blood pressure, or bleeding risk.
    What Is the FDA’s Role in Dietary Supplements?
    Although the FDA has oversight of the dietary supplement industry, the supplement manufacturers and distributors are responsible for making sure their products are safe before they’re marketed. Manufacturers are required to produce dietary supplements that meet minimum quality standards, do not contain contaminants or impurities, and are accurately labeled.
    The FDA does not review supplements for effectiveness (as it does for OTC and prescription medications) before they enter the market. If the dietary supplement contains certain new dietary ingredients, the manufacturer must submit data on that ingredient’s safety—but not its effectiveness—for the FDA’s review before the manufacturer markets a dietary supplement containing the ingredient.
    The FDA can take enforcement actions against manufacturers if their products are found to be adulterated (for example, if an ingredient is unsafe) and/or misbranded (for example, if their labeling is false or misleading). To the extent a product marketed as a dietary supplement bears claims that the product is intended to diagnose, mitigate, treat, cure, or prevent a disease, the FDA may also consider whether it is appropriate to take action against products that are unlawfully marketed as drugs.
    Talk With Your Health Care Professional Before Using Supplements
    Before you take any dietary supplement or medication—over-the-counter or prescription—it is important to discuss it with your health care professional.

    Every time you visit a health care professional’s office, bring a list of all the dietary supplements and medications you are currently taking. Include the dosages and how many times a day you take them. Some people find it easiest to throw all their dietary supplements and medications in a bag to bring to the medical visit.
    If you’re thinking of adding a dietary supplement to your daily routine, call your health care professional first, and let them know what other supplements and medications you’re taking.
    Also, tell your health care professional if your health status has changed, particularly if you are pregnant, breastfeeding, or have had any recent illnesses or surgery.

    Additional Resources:
    Dietary Supplements, FDA Information for Consumers on Using Dietary Supplements, FDA

    MIL OSI USA News

  • MIL-OSI USA: University High Knows the Answers at NASA JPL Regional Science Bowl

    Source: NASA

    In a fast-paced competition, students showcased their knowledge across a wide range of science and math topics.
    What is the molecular geometry of sulfur tetrafluoride? Which layer of the Sun is thickest? What is the average of the first 10 prime numbers? If you answered “see-saw,” “radiation zone,” and “12.9,” respectively, then you know a tiny fraction of what high school students must learn to compete successfully in the National Science Bowl.
    On Saturday, March 1, students from University High School in Irvine answered enough of these kind of challenging questions correctly to earn the points to defeat 19 other high school teams, winning a regional Science Bowl competition hosted by NASA’s Jet Propulsion Laboratory in Southern California. Troy High, from Fullerton, won second place, while Arcadia High placed third.
    Some 100 students gathered at JPL for the fast-paced event, which drew schools from across Los Angeles, Orange, and San Bernardino counties. Teams are composed of four students and one alternate, with a teacher serving as coach. Two teams at a time face off in a round robin tournament, followed by tie-breaker and double-elimination rounds, then final matches.

    The questions — in biology, chemistry, Earth and space science, energy, mathematics, and physics — are at a college first-year level. Students spend months preparing, studying, quizzing each other, and practicing with “Jeopardy!”-style buzzers.
    It was the third year in a row for a University victory at the JPL-hosted event, and the championship round with Troy was a nail-biter until the very last question. The University team only had one returning student from the previous year’s team, junior Feodor Yevtushenko. Both he and longtime team coach and science teacher David Knight said the key to success is specialization — with each student focusing on particular topic areas.
    “I wake up and grind math before school,” Feodor said. “Being a jack-of-all-trades means you’re a jack-of-no-trades. You need ruthless precision and ruthless speed.”
    University also won for four years in row from 2018 to 2021. The school’s victory this year enables its team to travel to Washington in late April and vie for ultimate dominance alongside other regional event winners in the national finals.
    More than 10,000 students compete in some 115 regional events held across the country. Managed by the U.S. Department of Energy, the National Science Bowl was created in 1991 to make math and science fun for students, and to encourage them to pursue careers in those fields. It’s one of the largest academic competitions in the United States.
    JPL’s Public Services Office coordinates the regional contest with the help of volunteers from laboratory staff and former Science Bowl participants in the local community. This year marked JPL’s 33rd hosting the event.
    News Media Contact
    Melissa PamerJet Propulsion Laboratory, Pasadena, Calif.626-314-4928melissa.pamer@jpl.nasa.gov
    2025-030      

    MIL OSI USA News

  • MIL-OSI USA: NACA Test Pilot Poses with Plane

    Source: NASA

    In this 1957 photo, George Cooper, a test pilot for the National Advisory Committee for Aeronautics, or NACA, stands next to a North American F-100, a supersonic fighter tested by the NACA. Cooper served as a pilot in World War II before being hired at the NACA’s Ames Aeronautical Laboratory in 1945. Between 1945 and his retirement in 1973, Cooper tested over 135 aircraft, routinely pushing them to their limits.
    On March 3, 1915, the NACA was established by Congress to “supervise and direct the scientific study of the problems of flight, with a view to their practical solution.” Over the course of its 43 years, the NACA became home to many of the nation’s best and brightest aeronautical engineers and world-class facilities. America’s flight capabilities for military and commercial uses were advanced through its cutting-edge research. It was upon this foundation that America’s civilian space agency was built. With the passing of the Space Act in 1958, the NACA was transformed into NASA and tasked with researching problems of flight in both the air and in space.
    Celebrate the 110th anniversary of the founding of the NACA with a new video series.
    Image credit: NASA

    MIL OSI USA News

  • MIL-OSI USA: DCCA NEWS RELEASE: DCCA TO HOST NATIONAL CONSUMER PROTECTION WEEK FAIR

    Source: US State of Hawaii

    DCCA NEWS RELEASE: DCCA TO HOST NATIONAL CONSUMER PROTECTION WEEK FAIR

    Posted on Mar 3, 2025 in Latest Department News, Newsroom

    STATE OF HAWAIʻI

    KA MOKU ʻĀINA O HAWAIʻI

     

    DEPARTMENT OF COMMERCE AND CONSUMER AFFAIRS

    KA ʻOIHANA PILI KĀLEPA

     

    JOSH GREEN, M.D.

    GOVERNOR

    KE KIAʻĀINA

     

    NADINE Y. ANDO

    DIRECTOR

    KA LUNA HOʻOKELE

    DCCA TO HOST NATIONAL CONSUMER PROTECTION WEEK FAIR

    Annual Event Brings Together Dozens of Organizations

     

    FOR IMMEDIATE RELEASE

    March 3, 2025

    HONOLULU — National Consumer Protection Week (NCPW) starts today, March 3, 2025, and serves as a significant annual event dedicated to raising awareness about consumer rights and educating the public on avoiding frauds and scams. The Department of Commerce and Consumer Affairs (DCCA) will commemorate NCPW by hosting a free Consumer Protection Fair from 11:00 a.m. to 1:30 p.m. on Thursday, March 6 on the fourth floor of the State Capitol at 415 South Beretania Street. Metered parking is available for the public.  

     

    “Consumer awareness is the first line of defense against fraud and exploitation. As we commemorate National Consumer Protection Week through our annual fair, the DCCA remains committed to providing the public with the resources and support necessary to navigate the complexities of today’s marketplace,” said DCCA Director Nadine Ando.

     

    Organizations participating in the National Consumer Protection Week Fair on Thursday, March 6, include:

    • Better Business Bureau
    • Blood Bank of Hawai‘i
    • Elderly Affairs Division – City and County of Honolulu
    • Tax Relief Section – City and County of Honolulu
    • Real Property Assessment Division – City and County of Honolulu
    • Executive Office on Aging – Senior Medicare Patrol (SMP)
    • Hawai‘i Credit Union League
    • Hawai‘i Emergency Management Agency (HIEMA)
    • Hawai‘i Family Caregiver Coalition
    • Hawai‘i HomeOwnership Center
    • Hawai‘i Pacific University
    • Hawai‘i State Health Insurance Assistance Program (Hawai‘i SHIP)
    • Hawaiian Community Assets
    • Hawaiian Electric Co.
    • HMSA
    • Honolulu Fire Department – City and County of Honolulu
    • IRS – Taxpayer Advocate Service
    • Long-Term Care Ombudsman Program – State of Hawai‘i
    • Neighborhood Commission Office
    • 911 Board – State of Hawai‘i
    • Dept. of Taxation – State of Hawai‘i
    • Public Utilities Commission – State of Hawai‘i
    • Mediation Center of the Pacific
    • U.S. Attorney’s Office – District of Hawai‘i
    • The state of Hawai‘i Department of Commerce and Consumer Affairs (DCCA)
    • Business Action Center
    • Investor Education Program
    • Consumer Education Program
    • Division of Financial Institutions
    • Insurance Division
    • Office of Consumer Protection
    • Personnel Office
    • Public Utilities Commission
    • Real Estate Branch
    • Regulated Industries Complaints Office – Consumer Resource Center

    ###

    Media Contact:

    Communications Office
    Department of Commerce and Consumer Affairs

    Phone: 808-586-2760
    Email:
    [email protected]

    MIL OSI USA News

  • MIL-OSI Economics: Thales reports its 2024 full-year results

    Source: Thales Group

    Headline: Thales reports its 2024 full-year results

    • Order intake: €25.3 billion, up 9% (+6% on an organic basis1)
    • Sales: €20.6 billion, up 11.7% (+8.3% on an organic basis)
    • Adjusted EBIT2: €2,419 million, up 13.4% (+5.7% on an organic basis)
    • Adjusted net income, Group share2: €1,900 million, up 7%
    • Consolidated net income, Group share: €1,420 million, up sharply by 39%
    • Free operating cash flow from continuing operations 2,3: €2,142 million, up 9%
    • Free operating cash flow2: €2,027 million, stable against 2023
    • Dividend4of €3.70 per share, representing 40% of Adjusted net income, Group share
    • Non-financial performance: steady progress towards medium to long-term targets
    • 2025 objectives:
      • Book-to-bill5above 1
      • Organic sales growth of between +5% and +6%, corresponding to sales between €21.7 billion and €21.9 billion
      • Adjusted EBIT margin between 12.2% and 12.4%

    Thales’s Board of Directors (Euronext Paris: HO) met on March 3, 2025 to review the 2024 financial statements6.

    “2024 was once again a year of strong profitable growth for Thales.

    ​Thales, a world leader in advanced technologies in Defence, Aerospace, Cybersecurity and Digital, maintained excellent sales momentum throughout the year, achieving a record order intake of more than €25 billion. The record order book provides unprecedented visibility for all our activities.
    ​Sales exceeded the €20 billion mark with organic growth of 8.3%, above expectations. Defence activities, underpinned by an ongoing increase in the Group’s production capacity, the technological excellence of our products and the commitment from all our colleagues, contributed in particular to this performance.
    ​Thales also demonstrated once again its ability to generate profitable growth, with an increase in EBIT in absolute terms and as a percentage, reflecting the strength of its operating leverage.
    ​Thanks to its unique business model based on world-class products, systems and services, Thales generated free operating cash flow of more than €2 billion.
    ​Non-financial performance was also remarkable in 2024. The validity of our CSR strategy was acknowledged as Thales joined the CAC 40 ESG index in 2024.
    ​This historic performance is the result of the unfailing commitment of our 83,000 employees, and I would like to thank them sincerely for their dedication to our clients.

    ​We are starting 2025 with confidence and determination and a positive outlook for the vast majority of our activities. Thales presented its new strategic roadmap in November 2024. By drawing on its unique leadership positions serving growing markets and its ability to innovate and anticipate technological breakthroughs, the Group affirms its ambition to deliver accelerated, profitable and sustainable growth over the coming years, starting in 2025.”

    Patrice Caine, Chairman & Chief Executive Officer

    Key figures

    Order intake for the 2024 financial year increased by 9% compared with 2023 at €25,289 million and by +6% on an organic basis (i.e. at constant scope and exchange rates). Commercial performance was once again supported by strong demand in the Defence segment and by continued sustained momentum in the Aerospace segment. As at 31 December 2024, the consolidated order book amounted to nearly €51 billion, a record level, up by nearly €5.4 billion compared with the end of 2023.

    Sales totaled €20,577 million, up 11.7% from 2023 (+8.3% in organic growth). This robust growth reflects in particular the solid performance of the Defence business throughout the year.

    Adjusted EBIT7 stood at €2,419 million in 2024 (11.8% of sales), compared with €2,132 million (11.6% of sales) in 2023, an increase of 13.4% (+5.7% organic change).

    At €1,900 million, Adjusted net income, Group share7 was up +7% compared to 2023.

    Consolidated net income, Group share, stood at €1,420 million, up sharply by +39% from 2023. This increase can be explained notably by the recognition in 2023 of a non-current and non-recurring expense linked to the implementation of insurance coverage for the Group’s commitments under the Thales UK Pension Scheme. These commitments were transferred to Rothesay at the end of 2023.

    Free operating cash flow from continuing operations7,9 amounted to €2,142 million, compared with €1,968 million in 2023. Including the contribution of discontinued operations, free operating cash flow7 amounted to €2,027 million, compared with €2,026 million in 2023.
    ​Calculated on the basis of the scope of continuing operations, the cash conversion ratio of Adjusted net income, Group share, into operating free cash flow was 114%. This once again exceptional performance, which saw the cash conversion ratio exceed 100% for the fifth consecutive year, reflects the excellent momentum of new orders, the phasing effects on cash inflows related to contracts’ execution and the continued Group’s mobilization of its CA$H! plan aimed at optimizing this conversion ratio.

    In this context, the Board of Directors decided to propose the payment of a dividend of €3.70 per share, corresponding to a payout ratio of 40% of the Adjusted net income, Group share. An interim dividend of €0.85 per share was paid on December 5, 2024. The balance of €2.85 will be paid on May 22, 2025.

    Order intake

    Order intake for the 2024 financial year totaled €25,289 million, up 9% from 2023 in total change and up +6% at constant scope and exchange rates11. For the fourth consecutive year, the order intake was more than 20% higher than sales (book-to-bill). Thebook-to-bill ratio was 1.23, flat against 2023, and 1.28 excluding the Cyber & Digital business, where the order intake is structurally very close to sales.

    In 2024, Thales signed 35 large orders with a unit value of over €100 million, representing a total of €8,674 million:

    • Four large orders booked in Q1 2024:
      • The entry into force of the third phase of the order placed by Indonesia in 2022 for the purchase of 42 Rafale aircraft (18 aircraft and support services);
      • Phased contract with the French Defence Procurement Agency (DGA) to develop the next generation of sonars to equip French nuclear-powered ballistic-missile submarines (SSBN);
      • Order of an aerial surveillance system for a military customer in the Middle East;
      • Second tranche of the contract signed in 2023 between France and Italy for the production of 400 ASTER B1NT ground-to-air missiles.
    • Eight large orders booked in Q2 2024:
      • Order for a next generation cloud native “FLYTEDGE” InFlight Entertainment System for a major worldwide airline;
      • Order by SKY Perfect JSAT to Thales Alenia Space of JSAT-31, a new generation of satellite reconfigurable in orbit using Space INSPIRE technology;
      • Exomars 2028, a contract signed between industrial prime contractor Thales Alenia Space and the European Space Agency (ESA) to relaunch the European space mission dedicated to the exploration of the Red Planet;
      • Order of two new F126 frigates by the German Navy. This additional contract brings the number of F126 frigates acquired by the German Navy to six in the past four years;
      • Order by the Dutch Ministry of Defence of seven additional Ground Master 200 multi-mission compact radars;
      • Service contract for the maintenance of the Royal Australian Navy fleet;
      • Order by an Asian customer of latest-generation Ground Master 400 Alpha long-range air surveillance radars;
      • Order by France’s Joint Munitions Command (SiMu) of tens of thousands of 120mm rifled ammunition.
    • Seven major orders recorded in Q3 2024:
      • Notification by the DGA of the second tranche of the development of the future RBE2 XG radar for the Rafale F5;
      • Order for the supply of anti-submarine warfare systems for the first phase of the construction of six HUNTER-class frigates for the Royal Australian Navy;
      • Order for the renovation of an air traffic management system;
      • Order from the UK Ministry of Defence for the supply of Lightweight Multi-role Missiles (LMM) to strengthen Ukraine’s air defence capabilities;
      • Order of LMM for the British armed forces;
      • Order for the supply of Ground Fire multifunction radar and engagement modules following France’s acquisition of seven SAMP/T NG air defence systems;
      • Order for the supply of communications, vetronics, navigation and optronics equipment for vehicles in the French Army’s SCORPION program.
    • Sixteen large orders booked in Q4 2024:
      • Order for the supply of a satellite for the European Space Agency’s EnVision scientific mission to understand the planet Venus;
      • Contract amendment signed with OHB System for the payload of the third satellite of the European CO2M mission focused on CO2 emissions generated by human activity;
      • Amendment to the contract with the European Space Agency for the development of the ESPRIT communications and refueling module for the future lunar space station, Gateway;
      • Order for the development of the world’s first quantum key distribution (QKD) system from geostationary orbit, in collaboration with Hispasat;
      • Contract with the Mohammed Bin Rashid Space Centre to develop the Emirates Airlock Module on board the future lunar space station Gateway;
      • Entry into force of the contract for the supply of 12 Rafale to Serbia;
      • Order from Naval Group for the supply of equipment for the submarine delivery contract in the Netherlands;
      • Order under the AJISS contract to provide In-Service Support to Royal Canadian Navy ships;
      • Order for the development and production of 430 new-generation MICA-NG interception, combat and self-defence missile seekers;
      • Order from the UK Ministry of Defence for the development and preparation of large-scale production of STARStreak HVMs (High Velocity Missiles) for the armed forces;
      • Order from the French Air Navigation Services Directorate (DSNA) aimed at improving the 4-Flight air traffic management system;
      • Amendment to the CONTACT contract with the DGA providing the armed forces with a range of software-defined radios designed for collaborative combat;
      • Order from the UK Ministry of Defence to ensure the permanence and maneuverability of the Royal Navy’s operational communications;
      • Order from the DGA as part of the SYRACUSE IV program to equip the French army’s SCORPION vehicles with Thales’ secure satellite communications solution;
      • Order from the DGA for the design, delivery and maintenance of a resilient communication system;
      • Order from the DGA to produce an encryption key management and distribution system and key injector for the Ministry of the Armed Forces.

    With a total amount of €16,615 million, order intake with a unit value of less than €100 million continued to record favorable momentum.

    Geographically12, order intake in mature markets amounted to €19,010 million, very close to that recorded in 2023, which though included the £1.8 billion MSET contract in the United Kingdom. Sales momentum elsewhere was also solid, particularly in the rest of Europe (up by 16% on an organic basis) and in Australia and New Zealand (up by 13% on an organic basis). Order intake in emerging markets was up sharply in 2024, amounting to €6,279 million (+39% at constant scope and exchange rates) thanks to continued strong momentum in the Near and Middle East (with an organic increase of 80%).

    Order intake in the Aerospace segment totaled €6,434 million compared to €5,606 million in 2023 (+14% at constant scope and exchange rates). This solid growth reflects several trends.

    • The different segments of the Avionics market continued to record sustained demand in 2024;
    • The Space business posted sustained growth in order intake, including five orders with a unit value of more than €100 million recorded in the fourth quarter, four of which in OEN (Observation, Exploration & Science and Navigation) activities.
    • At December 31, 2024, the segment’s order book stood at €10.5 billion, up 13% from 2023.

    At €14,723 million compared to €13,944 million in 2023, order intake in the Defence segment set a new record (+5% at constant scope and exchange rates). The book-to-bill ratio was 1.34, above 1.2 for the sixth consecutive year. This high level is explained by continued strong demand in all activities, with twenty-seven contracts with a unit value of more than €100 million recorded in 2024. The segment’s order book reached a new record at €39.2 billion (up 12%), corresponding to 3.6 years of sales, offering strong visibility for the years ahead.

    At 4,032 million, order intake in the Cyber & Digital segment was structurally very close to sales as most business lines in this segment operate on short sales cycles. The order book is therefore not significant.

    Sales

    Note: full-year 2023 figures have been restated to reflect the transfer of cyber civil activities from the Defence segment to the Cyber & Digital segment.

    Sales for the 2024 financial year totaled €20,577 million, compared to €18,428 million in 2023, up 11.7% in total change and 8.3% in organic terms (at constant scope and exchange rates14), driven in particular by the robust performance of the Defence segment.

    Geographically15, sales recorded solid growth in both mature markets (+7.9% in organic terms) and emerging markets (+9.6% in organic terms), driven by double-digit growth in Asia.

    Sales in the Aerospace segment totaled €5,471 million, up 4.8% from 2023 (+2.9% at constant scope and exchange rates). Momentum in this segment reflects contrasting trends:

    • The Avionics business posted mid-single digit organic growth in 2024, notably driven by strong momentum in both original equipment activities and aftermarket services, with a return to pre-Covid levels in air traffic. However, as expected, the fourth quarter was impacted by delays in aircraft deliveries to airlines, which postponed in-flight entertainment (IFE) sales;
    • As expected, sales were almost flat in the Space business. The telecommunications segment continued to be impacted by structurally lower demand in the geostationary satellite market. Conversely, trends remain positive for OEN activities.

    Sales in the Defence segment totaled €10,969 million, up 13.9% from 2023 (+13.3% at constant scope and exchange rates). This strong growth came against a backdrop of steady growth in the Group’s production capacity, enabling it to meet high demand in all product lines. Growth was notably driven by land and air systems, such as tactical vehicles and systems or surface radars. The fourth quarter of 2024 also benefited from favorable cut-off effects.

    At €4,024 million, sales in the Cyber & Digital segment increased by 1.4% at constant scope and exchange rates (and +14.8% in total change including the positive scope effect of the acquisitions of Imperva and Tesserent). This moderate organic sales growth reflects different trends depending on the activities:

    • Strong momentum continued for cyber businesses, including a strong performance from Imperva;
    • Against a high comparison basis in 2023, payment services sales were impacted by destocking by our customers in North America;
    • Lastly, the digitalization of secure connectivity solutions maintained its strong growth. Sales generated in fully digital connectivity solutions (including eSIMs and on-demand connectivity platforms) recorded double-digit organic growth and accounted for more than half of sales of this secure connectivity solutions business in 2024.

    Results

    For 2024, the Group posted Adjusted EBIT16 of €2,419 million, or 11.8% of sales, compared to €2,132 million (11.6% of sales) in 2023.

    The Aerospace segment recorded Adjusted EBIT of €391 million (7.2% of sales), compared with €369 million (7.1% of sales) in 2023. The segment’s Adjusted EBIT margin is driven by the Avionics business, which posted a double-digit margin and improving, including the contribution of Cobham AeroComms. However, Space activities weighed on the segment’s margin, recording as expected a negative Adjusted EBIT margin in 2024 resulting from several factors: an expected increase in R&D spending, restructuring costs linked to the adaptation plan announced in March 2024 and the impact of inflation not reflected on past contracts.

    Adjusted EBIT for the Defence segment amounted to €1,432 million, compared with €1,270 million in 2023 (an increase of +13.0% at constant scope and exchange rates). The margin for this segment was stable at 13.1%, compared to 13.2% in 2023.

    At €585 million (14.5% of sales), Adjusted EBIT in the Cyber & Digital segment recorded solid growth in both value and margin. The improvement in profitability was notably due to the successful integration of Imperva and the robust margin on payment services and secure connectivity solutions for mobile networks in highly competitive markets.

    Naval Group’s contribution to the Group’s Adjusted EBIT amounted to €93 million in 2024, compared with €91 million in 2023.

    At -€166 million, compared with €2 million in 2023, net financial interest increased sharply, as expected. This increase was mainly linked to the substantial rise in debt following the acquisitions made in 2023. Other adjusted financial income16 stood at €35 million in 2024 versus -€37 million in 2023, reflecting the exceptional positive impact of dividends on non-consolidated affiliates and foreign exchange gains. The adjusted financial expense on pensions and other long-term employee benefits16 improved significantly (-€49 million compared with -€76 million in 2023), reflecting the removal of the interest expense following the transfer of UK pension obligations in December 2023.

    At €21 million, compared with €105 million in 2023, the Adjusted net income, Group share, from discontinued operations16 was in line with trends in the Transport business, which was sold on May 31, 2024.

    As a result, Adjusted net income, Group share16 was €1,900 million, compared to €1,768 million in 2023, after an adjusted income tax charge16 of -€427 million, compared to -€370 million in 2023. At 20.4% in 2024 compared to 20.1% in 2023, the effective tax rate was stable.

    The Adjusted net income, Group share, per share16 amounted to €9.24, up 9% from 2023 (€8.48).

    Consolidated net income, Group share, stood at €1,420 million, up 39% from 2023. This increase can be explained notably by the recognition in 2023 of a non-current and non-recurring expense linked to the implementation of insurance coverage for the Group’s commitments under the Thales UK Pension Scheme.

    Financial position at December 31, 2024

    Free operating cash flow17 amounted to €2,027 million compared to €2,026 million in 2023. It included a contribution of €2,142 million from continuing operations and -€116 million from discontinued operations. For continuing operations, the cash conversion ratio of Adjusted net income, Group share, into free operating cash flow was 114%.

    The net balance of acquisitions and disposals of subsidiaries and affiliates amounted to €359 million. Under its acquisition strategy, the Group completed two major operations in 2024:

    • The acquisition (on April 2, 2024) of Cobham Aerospace Communications, a leading supplier of cutting-edge technologies enabling flexible, integrated and more-autonomous avionics systems, based primarily in the United States and generating sales of approximately $200 million in 2023 (see press releases dated July 12, 2023 and April 2, 2024);
    • The sale (on 31 May 2024) to Hitachi Rail of the Transport business, a global leader in rail signaling and train control systems, telecommunications and supervision systems, and fare collection solutions (see press releases dated August 4, 2021 and May 31, 2024). This business generated sales of €1,822 million in 2023.

    As part of the share buyback program covering a maximum of 3.5% of the capital announced in March 2022 and completed in March 2024, 1,245,757 shares were repurchased during 2024, representing 0.6% of the share capital, for €176 million. The Group repurchased a total of 7,469,396 shares under this program, 3.5% of the share capital.

    At December 31, 2024, net debt amounted to €3,044 million compared with €4,190 million at December 31, 2023. This decrease reflects the impact of free operating cash flow generation, acquisitions and disposals for -€359 million (€3,464 million in 2023), the payment of €708 million in dividends (€634 million in 2023), new lease liabilities for €143 million (€166 million in 2023) and the share buyback program.

    Equity, Group share amounted to €7,515 million, compared with €6,830 million at December 31, 2023. This increase reflects the positive contribution of consolidated net income, Group share (€1,420 million) less the dividend payout (-€708 million) and share buybacks (-€176 million).

    Non-financial performance

    In line with its corporate purpose of “Building a future we can all trust”, Thales has set itself the ambition in terms of Corporate Social Responsibility (CSR): to contribute to a safer, greener and more inclusive world. First, the Group will seek to maximize the contribution of its portfolio of solutions to the planet and society. Secondly, Thales has set itself ambitious targets on three main priorities:

    • The fight against global warming;
    • Strengthening gender diversity at all levels;
    • The implementation of the best standards in terms of ethics and compliance.

    In terms of the fight against global warming, scope 1 & 2 CO2 emissions fell by 56.8% in 2024 compared to 2018 and scope 3 emissions fell by 24.7% compared to 2018. The Group has thus achieved its 2030 targets ahead of schedule for the second consecutive year. The absolute value reduction targets for carbon footprint remain relevant for 2030 given the Group’s growth prospects. To raise employee awareness to climate change and its impacts on society and on the Group, a voluntary training named “Thales Climate Passport” was deployed in 2024 with the aim of training 50% of managers. Over 67.4% of managers, representing around 35,000 employees, completed this training course in 2024, demonstrating the great success of this training.

    With regard to strengthening diversity, Thales has set itself an ambitious target for 2026 to have 75% of management committees with at least 4 women. Thus, at the end of 2024, 61.5% of the Group’s management committees had at least 4 women, compared to 52.6% at the end of 2023. The highest levels of responsibility comprised 21.1% women at the end of 2024[1]; a performance in line with the Group’s trajectory to reach the set goal of 22.5% by 2026 (compared to 20.4% at the end of 2023 and 16.6% at the end of 2018).

    In the area of ethics and compliance, 100% of employees concerned by the 2024 anti-corruption training campaign have been trained, demonstrating the Group’s continuous commitment to train all employees potentially exposed to risk situations. In 2024, the ISO 37001 certification “Anti-bribery management systems” was renewed for 3 years and extended to Germany, Australia, and New Zealand after Canada and the United States in 2023, and the United Kingdom and the Netherlands in 2022. Thus, in 2024, the revenue generated by certified entities represents 64% of the Group’s revenue (vs. 58% in 2023).

    [1] Percentage of women in the total workforce: 27.4%.

    Proposed dividend

    The Board of Directors decided to propose to the shareholders, who will convene at the Annual General Meeting on May 16, 2025, the payment of a dividend of €3.70 per share. This corresponds to a payout ratio of 40% of the Adjusted net income, Group share, per share.

    If approved, the ex-dividend date will be May 20, 2025, and the payment date will be May 22 2025. This dividend will be paid fully in cash and will amount to €2.85 per share, after deducting the interim dividend of €0.85 per share paid in December 2024.

    Outlook

    Thales is embarking on 2025 with confidence, bolstered by good visibility in the vast majority of its activities.

    In 2025, the Avionics business will be driven by both the original equipment and aftermarket services activities, the continued growth of the Cobham AeroComms business, and the gradual recovery of the IFE business. In the Space business, the outlook remains positive, particularly in the Observation, Exploration & Science, Navigation and military telecommunications activities. However, the structural weakness of demand in the geostationary satellite market will dampen the growth of this activity. Thales will continue to implement its cost adaptation plan, with the objective of an Adjusted EBIT margin of 7%+ in the Space business in 2028.

    The Defence segment, which enjoys a record order book, will be further supported by strong demand in 2025, against a backdrop of increasing military spending, particularly in the geographical areas where the Group operates. With the increase in its production capacity over the past several years and a portfolio of premium solutions incorporating differentiating leading technologies, Thales is ideally positioned to meet its customers’ needs.

    Lastly, the Cyber and Digital segment will benefit from positive momentum in 2025, supported by Thales’ unique positioning and leadership. The continued development of Imperva will strengthen the differentiating value proposition in cybersecurity activities in order to take advantage of the buoyant environment. The payment services business is also expected to gradually return to growth.

    The Group expects net investment expenses to slightly exceed €700 million in 2025 (after €617 million in 2024) to meet the need to increase production capacity, particularly in the Defence business.

    As a result, Thales sets the following targets for 2025:

    • A book-to-bill ratio above 1;
    • Organic sales growth of between +5% and +6%, corresponding to sales in the range of €21.7 billion to €21.9 billion;
    • An Adjusted EBIT18 margin between 12.2% and 12.4%, up 40 to 60 basis points from 2024.

    The Group also expects to maintain a high cash conversion ratio of between 95% and 100% in 2025.

    Note: assuming no new major disruptions of macroeconomic and geopolitical context; including tariff increase.

    Impact of new tax measures in France

    Following the adoption of the 2025 budget, which introduces various tax changes, the impacts for the Thales Group are as follows:

    • An additional tax expense of ~€80 million related to the temporary additional corporate tax charge, giving rise to an additional tax of 41.2% in 2025, resulting in an overall tax rate of 36.13% (instead of the current rate of 25.83%);
    • ~€8 million in taxes payable on share cancellations made in October 2024 as part of the share buyback program.

    The temporary additional contribution to corporate tax for Naval Group could have a negative impact of around €8 million on Thales’ Adjusted EBIT in 2025.

    These different impacts will represent an equivalent cash outflow in 2025.

    ****

    This press release contains certain forward-looking statements. Although Thales believes that its expectations are based on reasonable assumptions, actual results may differ significantly from the forward-looking statements due to various risks and uncertainties, as described in the Company’s Universal Registration Document, which has been filed with the French financial markets authority (Autorité des marchés financiers – AMF).


    1 In this press release, “organic” means “at constant scope and exchange rates”. See note on methodology on page 18 and calculation on page 23.

    2 Non-GAAP financial indicators, see definitions in the appendices, page 18. The title “EBIT” has been amended to “Adjusted EBIT”, in accordance with ESMA’s recommendation.The definition remains unchanged.

    3 Operating free cash flow from continuing operations, excluding the Transport activity sold on May 31, 2024.

    4 Proposed to the Annual General Meeting on May 16, 2025.

    5 Ratio of order intake to sales.

    6 As at the date of this press release, the verification process on the sustainability information is ongoing. With the exception of the possible impact of the conclusions of this process, the audit procedures have been carried out. The audit report will be issued following the Board of Directors’ meeting on April 2, after the finalization of the procedures related to sustainability information.

    7 Non-GAAP financial indicators, see definitions in the appendices, page 18.

    8 Proposed to the Annual General Meeting on May 16, 2025.

    9 Free operating cash flow from continuing operations, excluding the Transport activity sold on May 31, 2024.

    10 Mature markets: Europe, North America, Australia, New Zealand; emerging markets: all other countries. See table on page 22.

    11 Taking into account a currency effect of €49 million and a net scope effect of €625 million.

    12 See table on page 22.

    13 Mature markets: Europe, North America, Australia, New Zealand; emerging markets: all other countries. See table on page 22.

    14 The calculation of the organic change in sales is shown on page 23.

    15 See table on page 22.

    16 Non-GAAP financial indicator, see definition in the appendices, page 18 and calculation, pages 20 and 21.

    17 Non-GAAP financial indicator, see definition in the appendices, page 18.

    18 The title “EBIT” has been amended to “Adjusted EBIT”, in accordance with ESMA’s recommendation.The definition remains unchanged.

    MIL OSI Economics

  • MIL-OSI Video: Gaza, Syria & other topics – Daily Press Briefing | United Nations

    Source: United Nations (Video News)

    Noon Briefing by Stéphane Dujarric, Spokesperson for the Secretary-General.

    Highlights:

    – Secretary-General/Cairo Summit
    – Gaza
    – Occupied Palestinian Territory
    – Syria
    – Ukraine
    – Democratic Republic of the Congo
    – Human Rights
    – Haiti
    – Bangladesh
    – Resident Coordinator – Madagascar
    – World Wildlife Day
    – Briefings

    GAZA
    Also, you will have seen that yesterday, in a statement we released, the Secretary-General urged all parties to make every effort to prevent a return to the hostilities in Gaza. He calls for humanitarian aid to flow back into Gaza immediately and for the release of all hostages.
    Tom Fletcher, our Emergency Relief Coordinator, said that Israel’s decision to halt aid into Gaza is indeed alarming. He added that international humanitarian law is clear: we must be allowed access to deliver vital lifesaving aid. We need to get aid in and the hostages out, he said.
    Earlier on the weekend, on Saturday, the Secretary-General, in a statement in which he noted that thousands of trucks carrying life-saving assistance had entered Gaza during the past six weeks, with aid having reached nearly every person in the Strip. And that statement was shared with you.
    And he added that as Ramadan – a time of peace and reflection – begins, he calls on all sides to spare no efforts to end all violence. The UN stands ready to support all such endeavours.

    OCCUPIED PALESTINIAN TERRITORY
    And on the ground, since yesterday, the Kerem Shalom, Erez and Zikim crossings have been closed for cargo. This means that vital humanitarian assistance, including thousands of tents, remains undelivered.
    The Spokesman told reporters that every weekday in this room, we have been very clear and provided updates from our colleagues from the Office for the Coordination of Humanitarian Affairs on how the ceasefire has allowed ourselves and our partners to scale up the delivery of life-saving assistance to the people of Gaza. The ceasefire has provided the opportunity to distribute food, to distribute water, as well as shelter assistance and medical aid, allowing nearly everyone in Gaza to receive food parcels.
    Our humanitarian partners tell us that following the closure of the crossings into Gaza yesterday, flour and vegetable prices increased more than 100-fold. Partners are currently assessing the stocks that are currently available within the Gaza Strip.

    Full Highlights: https://www.un.org/sg/en/content/noon-briefing-highlight?date%5Bvalue%5D%5Bdate%5D=03%20March%202025

    https://www.youtube.com/watch?v=YC8IuWEt-ZI

    MIL OSI Video

  • MIL-OSI Video: NCA Pre-Eligibility and VA Burial Benefits 02.25.2025

    Source: United States of America – Federal Government Departments (video statements)

    This outreach webinar provides VA CF partners with information and resources from the National Cemetery Administration, Scheduling Office about the Pre-Need and Burial eligibility to aid in the process of internment in a VA National Cemetery. This presentation is open to Veterans, their families, their beneficiaries, and the general public.

    The panelists for this training are:

    1. Jay Dalrymple, Director, National Cemetery Scheduling Office, Deputy Director, Field Programs, National Cemetery Administration, U. S. Department of Veterans Affairs

    2. Steve Ecker, Assistant Director, National Cemetery Scheduling Office, National Cemetery Administration, U. S. Department of Veterans Affairs

    https://www.youtube.com/watch?v=lVLR4bSKuqI

    MIL OSI Video

  • MIL-OSI Video: Overview of VA Veteran Justice Outreach Programs Incl. Legal Services for Veterans Grant 02.19.2025

    Source: United States of America – Federal Government Departments (video statements)

    This webinar provides a brief overview of the benefits and services provided by the VA’s Veteran Justice Outreach Program, including the Legal Services for Veterans Grants Program. This briefing is open to Veterans, their families, and the general public.

    The panelists for this training are:

    1. Sean Clark, National Director, Veterans Justice Programs (VJP), VHA Homeless Programs Office, Veterans Health Administration (VHA), U.S. Department of Veterans Affairs

    2. Madolyn Gingell, National Coordinator, Legal Services for Veterans, Veterans Justice Programs (VJP), VHA Homeless Programs Office, Veterans Health Administration (VHA), U.S. Department of Veterans Affairs

    https://www.youtube.com/watch?v=hN0Nhhr4wEU

    MIL OSI Video

  • MIL-OSI United Nations: Center for Research in Integrated Risk Management of the Autonomous University of Baja California Sur (CIGIR-UABCS)

    Source: UNISDR Disaster Risk Reduction

    Mission

    The “Centro de Investigación en Gestión Integral del Riesgo de la Universidad Autónoma de Baja California Sur (CIGIR-UABCS)” (Center for Research in Integrated Risk Management) arises from a need to have a multidisciplinary group of researchers focused on the detailed study of the disturbing phenomena that impact the state of Baja California Sur and the Northwest of Mexico, as well as the research and proposal of strategies to reduce vulnerability and exposure and therefore reduce and manage the risks that endanger communities.

    CIGIR is attached to the Academic Department of Fisheries Engineering of the Autonomous University of Baja California Sur.

    MIL OSI United Nations News

  • MIL-OSI: New Equifax Report: Fraud Concerns are Escalating with 89 per cent of Canadians Saying Companies Must Do More

    Source: GlobeNewswire (MIL-OSI)

    Seniors and Quebecers Report the Greatest Fraud Concerns
    – Equifax Canada Market Pulse Fraud Trends and Consumer Survey Report –

    TORONTO, March 04, 2025 (GLOBE NEWSWIRE) — Concerns about fraud are escalating among Canadians, with a new Equifax Canada survey* conducted ahead of Fraud Prevention Month revealing that 89 per cent of those surveyed believe companies must do more to protect personal data. Seniors and Quebec residents are particularly worried, demanding stronger fraud prevention measures and broader fraud education.

    Key findings of the survey:

    • More than half (55 per cent) of respondents believe identity thieves will always be one step ahead, with 51 per cent unsure of how to respond to fraud.
    • Seniors aged 65+ feel most at risk, with 96 per cent agreeing that companies must improve fraud protections, compared to 75 per cent of those aged 18-24.
    • Quebec (94 per cent) residents demanded the most action from companies on fraud prevention, while Alberta (86 per cent) was the lowest.
    • 64 per cent of respondents recognize that financial fraud fuels serious crimes like human trafficking and illegal weapons trade.
    • 58 per cent of respondents struggle to keep up with the latest scams, leaving many feeling vulnerable.
    • 48 per cent of respondents personally know someone who has been a victim of identity theft.

    “Fraud prevention is a major concern for many Canadians. Research shows that every dollar lost to a fraudster costs individuals and banks significantly more money. Companies must act now to strengthen fraud protection,” said Carl Davies, Head of Fraud & Identity at Equifax Canada. “Canadians, especially older adults, are demanding better safeguards to prevent financial crimes and identity theft.”

    The Auto Industry: A Hotspot for Fraud
    Auto fraud is a major concern with rates escalating in most provinces, particularly Ontario. According to recent Equifax Canada data, auto application fraud rate in Q4 2024 reached 0.26 per cent, up by 2 bps from Q3 2024 and up 9 bps when compared to 24 months ago. Falsified documents and inflated income are key drivers of first-party fraud in this sector, making up close to 80 per cent of all fraudulent applications. Consumers who are new-to-credit and new-to-Canada had significantly higher auto fraud rates in 2024 than other consumers — more than double the fraud rate that we see from consumers with more established credit files. Auto application fraud rates for those New to Canada/New to Credit in 2024 was 0.51 per cent compared to existing consumers at 0.22 per cent.

    Mortgage Fraud is Down but Falsified Financial Documents Remain a Challenge
    Equifax Canada is reporting that the Canadian mortgage market continues to slowly rebound from its lows in 2023, demonstrating growth in Q4 2024 with increased new mortgage accounts. Mortgage fraud rates have decreased significantly year-over-year, from 0.46 per cent in Q4 2023 to 0.19 per cent in Q4 2024. Despite this positive trend, falsified financial documents, such as bank statements and down payment information, remain a significant component of mortgage fraud at over 90 per cent. “This decline in fraud rates might be temporary. As interest rates gradually decrease, a potential surge in first-time buyers in 2025 could lead to increased fraudulent activity in mortgage credit applications. Consumers may misrepresent their financial information in an attempt to secure the best possible rates,” Davies warns.

    A Call for Stronger Corporate and Government Action
    Canadian survey respondents believe financial institutions, businesses, and the government all have a role to play in strengthening fraud prevention measures:

    • 88 per cent of respondents believe that both the public and private sectors must work together to combat financial crime
    • 84 per cent believe the government must improve public fraud education, with 91 per cent of seniors (65+) strongly agreeing
    • 77 per cent recognize the need to take personal steps to safeguard their data, but many feel unprepared
    • 61 per cent say banks should implement stronger security protocols
    • 59 per cent believe companies should leverage more sophisticated fraud detection tools

    Equifax Canada urges Canadians to take active steps in protecting their identities by regularly reviewing their credit reports for unusual activity, enabling multi-factor authentication on sensitive accounts, avoiding public WiFi for financial transactions, educating themselves on new fraud schemes, and consider investing in fraud protection services such as those offered by Equifax Canada.

    “As fraud tactics evolve, Canadians must remain vigilant,” added Davies. “By combining stronger corporate policies, government oversight, and personal diligence, we can make strides in fraud prevention.”

    * Equifax surveyed 1,590 Canadians ages 18-65, Feb. 7-9. A probability sample of the same size would yield a margin of error of +/- 2.5 per cent, 19 times out of 20.

    About Equifax
    At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.ca.

    Contact:

    Andrew Findlater
    SELECT Public Relations
    afindlater@selectpr.ca
    (647) 444-1197

    Angie Andich
    Equifax Canada Media Relations
    MediaRelationsCanada@equifax.com

    The MIL Network

  • MIL-OSI: Saras Micro Devices Announces Participation in CHIPS National Advanced Packaging Manufacturing Program Initiatives

    Source: GlobeNewswire (MIL-OSI)

    CHANDLER, Ariz., March 04, 2025 (GLOBE NEWSWIRE) — Saras Micro Devices (Saras), an emerging leader in cutting-edge system power performance solutions leveraging integrated packaging design, today announced its participation in two significant projects funded by the U.S. Department of Commerce CHIPS National Advanced Packaging Manufacturing Program (NAPMP). Each project was awarded $100 million in government funding.

    The first initiative is the Substrate-based Heterogeneous Integration Enabling Leadership Demonstration for the USA (SHIELD USA) project, led by Arizona State University (ASU) and Deca Technologies, Inc. The second is the Substrate and Materials Advanced Research and Technology (SMART) Packaging Program, led by Absolics, Inc. Saras will contribute its STILE™ product technology to both projects to enhance device package integration of advanced power delivery solutions for high-performance computing (HPC) and artificial intelligence (AI) applications.

    “Saras’ STILE technology enhances our substrate efforts,” said Jason Conrad, chief operating officer of ASU’s Southwest Advanced Prototyping (SWAP) Hub and site lead for MacroTechnology Works. “It adds functionality that complements our core development goals, helping to further elevate the capabilities of the advanced packaging solutions we’re developing.”

    Over the past year, Saras has secured seven foundational patents for its capacitor and STILE technologies from the United States Patent Trademark Office. This achievement underscores the company’s commitment to innovating critical solutions in power delivery for next-generation AI and HPC devices.

    “The power delivery challenges posed by AI require innovative solutions,” said Ron Huemoeller, CEO of Saras. “Our STILE technology addresses these challenges by enabling in-package power delivery close to the source, improving both efficiency and performance while opening up package real estate for higher levels of chiplet integration. By collaborating on the SHIELD USA and SMART projects, we’re able to contribute critical AI power delivery elements and, consequently, significantly advance U.S. semiconductor manufacturing capabilities.”

    STILE introduces a multi-domain, integrated passive module that embeds directly into the substrate core of device packages. This approach reduces the need for multiple function-specific devices, maximizes packaging real estate by optimizing space, and supports higher levels of chiplet integration—essential for the demands of AI workloads. The technology aligns with the goals of the NAPMP projects and will extend the advanced substrate technology solutions that the SHIELD USA project and SMART Packaging Program are focused on delivering.

    “This joint effort exemplifies how integrating complementary innovations can drive advancements in semiconductor packaging and address the performance demands of AI and HPC applications,” stated Craig Bishop, CTO of Deca Technologies. “SHIELD is truly a collaborative effort, combining Saras’ embedded passive technology with Deca’s novel interconnects at ASU’s research fab to demonstrate leap-ahead organic substrates.”

    The collaborations under the NAPMP advanced substrate and material projects highlight the importance of innovative power delivery solutions in maintaining U.S. leadership in semiconductor technology. By developing and scaling advanced packaging processes, materials, and equipment, these initiatives aim to create a robust foundation for high-volume semiconductor packaging production in the United States, enhancing national security and economic resilience.

    About Saras Micro Devices

    Established in 2021, Saras Micro Devices is revolutionizing the way power is delivered to advanced semiconductor devices. The company is developing custom and standard integrated passive modules that will significantly improve power performance and efficiency, addressing the challenges faced by the high-performance computing devices serving the growing demand for AI, ML, AR/VR, 5G/6G, and more. Instituted by an impressive team of advanced packaging experts with a combined 150+ years of experience in the microelectronics industry, Saras introduces an innovative embedded, 3D-integrated, vertical power delivery solution that enables higher per-watt performance, minimized routing losses, and greater overall efficiency while reducing the power management impact on the package footprint. Saras Micro Devices has simplified a currently complex solution for managing and optimizing power delivery. Uncover and explore further insights at sarasmicro.com.

    Media Contact:

    Mindy Lok, Kiterocket

    Phone: 480.240.8874

    Email: mlok@kiterocket.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/92979eb5-3ef8-458e-b3ac-501ec720a75b

    The MIL Network